https://investor.amarincorp.com/ 2025-02-24T09:59:04-05:00 daily 1.0 https://investor.amarincorp.com/committee-details/audit-committee 2025-06-03T14:45:00-04:00 0.5 https://investor.amarincorp.com/committee-details/renumation-committee 2025-07-30T13:20:37-04:00 0.5 https://investor.amarincorp.com/committee-details/board 2025-06-03T14:35:37-04:00 0.5 https://investor.amarincorp.com/committee-details/nominating-and-corporate-governance-committee 2025-07-30T12:57:09-04:00 0.5 https://investor.amarincorp.com/events/event-details/33rd-annual-jp-morgan-healthcare-conference 2015-01-05T03:52:24-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q4-results-conference-call 2015-02-23T11:35:45-05:00 0.5 https://investor.amarincorp.com/events/event-details/effects-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-pharmacokinetic 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effect-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-omeprazole-plasma 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/pharmacokinetics-eicosapentaenoic-acid-plasma-and-red-blood-cells-after 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-pure-epa-omega-3-fatty-acid-effects-plasma-and-red-blood-cell 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-treatment-hypertriglyceridemia 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-pure-ethyl-ester-eicosapentaenoic-acid-effects-circulating 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/efficacy-and-safety-eicosapentaenoic-acid-ethyl-ester-amr101-therapy-statin 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-pure-epa-omega-3-fatty-acid-effects-lipoprotein-particle 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-ethyl-ester-amr101-therapy-patients-very-high 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-amr101-lipid-and-inflammatory-parameters-patients-diabetes-mellitus-2 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-remnant-particle 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/high-sensitivity-c-reactive-protein-effects-icosapent-ethyl-eicosapentaenoic 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/pharmacokinetic-and-triglyceride-lowering-pharmacodynamic-effects-icosapent 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-amr101-pure-eicosapentaenoic-omega-3-fatty-acid-fatty-acid-profile 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/amr101-lowers-triglycerides-atherogenic-lipoprotein-phospholipase-a2-and-high 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-amr101-pure-ethyl-eicosapentaenoic-acid-omega-3-fatty-acid-lipoprotein 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-amr101-pure-epa-omega-3-fatty-acid-fatty-acid-profile-plasma-and-red 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-amr101-pure-epa-omega-3-fatty-acid-fatty-acid-profile-plasma-and-red-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/phase-1-study-effect-icosapent-ethyl-warfarin-pharmacokinetics-and 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/amr101-pure-ethyl-eicosapentaenoic-acid-omega-3-fatty-acid-effects 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/amr101-pure-epa-omega-3-fatty-acid-lowers-triglycerides-patients-very-high 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-eicosapentaenoic-acid-and-docosahexaenoic-acid-low-density-lipoprotein 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-pharmacokinetic-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-therapy-hypertriglyceridemic 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/retrospective-case-series-patients-diabetes-or-prediabetes-who-were-switched 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/perspectives-new-prescription-omega-3-fatty-acid-icosapent-ethyl 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/potential-benefits-icosapent-ethyl-lipid-profile-case-studies 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/overview-omega-3-fatty-acid-therapies 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-inhibited-glucose-induced-membrane-lipid-peroxidation 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-epa-inhibits-formation-membrane-cholesterol-crystalline 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/comparative-lipid-antioxidant-effects-omega-3-fatty-acids-combination-hmg-coa 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/update-marine-omega-3-fatty-acids-management-dyslipidemia-and-current-omega3 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/overview-prescription-omega-3-fatty-acid-products-hypertriglyceridemia 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/phase-1-study-effect-icosapent-ethyl-warfarin-pharmacokinetic-and 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/amr101-pure-epa-omega-3-fatty-acid-lowers-triglycerides-patients-very-high-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-eicosapentaenoic-acid-and-review 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-icosapent-ethyl-lipid-and-inflammatory-parameters-patients-diabetes 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-amr101-lipid-and-inflammatory-parameters-patients-diabetes-mellitus-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/phase-1-study-effect-icosapent-ethyl-atorvastatin-pharmacokinetics-healthy 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effect-two-doses-amr101-fasting-serum-triglycerides-and-other-lipid-parameters 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-inhibits-glucose-induced-membrane-cholesterol 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/new-pure-o-3-eicosapentaenoic-acid-ethyl-ester-amr101-management 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effect-concomitant-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-reduces-small-dense-low-density-lipoprotein-oxidation 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/combination-treatment-eicosapentaenoic-acid-and-atorvastatin-active-metabolite 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-icosapent-ethyl-lipoprotein-particle-concentration-and-size-statin 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-upon-high 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/first-quarter-2015-results-conference-call 2015-05-05T13:21:05-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-2015-global-healthcare-conference 2015-06-02T04:39:30-04:00 0.5 https://investor.amarincorp.com/events/event-details/combination-eicosapentaenoic-acid-and-statin-treatment-reversed-endothelial 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-epa-reduces-glucose-induced-small-dense-low-density 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/retrospective-case-series-lipid-effects-switching-omega-3-fatty-acid-ethyl 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-remnant-particle-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-remnant-particle-1 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/pharmacokinetic-and-triglyceride-lowering-pharmacodynamic-effects-icosapent-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/eicosapentaenoic-acid-epa-not-other-tg-lowering-agents-reduces-cholesterol 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-remnant-particle-2 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/pharmacokinetic-and-triglyceride-lowering-pharmacodynamic-effects-icosapent-1 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/effects-icosapent-ethyl-lipoprotein-particle-concentration-and-fatty-acid 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-apolipoprotein-c-iii 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/ballantyne-cm-bays-he-braeckman-ra-et-al-icosapent-ethyl-eicosapentaenoic-acid 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/pharmacokinetics-eicosapentaenoic-acid-plasma-and-red-blood-cells-after-0 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/pharmacokinetic-and-triglyceride-lowering-pharmacodynamic-effects-icosapent-2 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/recent-amarin-scientific-presentations 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/full-bibliography-amarin-scientific-presentations 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/chronological-order 2018-05-03T07:26:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-business-update 2018-09-24T08:20:05-04:00 0.5 https://investor.amarincorp.com/events/event-details/cantor-global-healthcare-conference-0 2018-09-28T11:28:59-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q3-results-conference-call 2018-11-01T05:17:41-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-schedules-webcast-discussion-primary-reduce-ittm-trial-results 2018-11-12T18:28:28-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-presentation-37th-annual-jp-morgan-healthcare-conference 2019-01-14T16:33:57-05:00 0.5 https://investor.amarincorp.com/events/event-details/8th-annual-svb-leerink-global-healthcare-conference 2019-02-28T10:00:15-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q3-results-conference-call-1 2019-02-26T19:10:30-05:00 0.5 https://investor.amarincorp.com/events/event-details/cowens-39th-annual-health-care-conference 2019-03-12T15:12:10-04:00 0.5 https://investor.amarincorp.com/events/event-details/acc-physician-panel-discussion 2019-03-18T14:54:57-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q1-results-conference-call 2019-05-01T05:12:43-04:00 0.5 https://investor.amarincorp.com/events/event-details/reduce-it-clinical-trial-results-brigham-and-womens-hospital-19-dec-2018 2019-04-24T14:03:41-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-2019-healthcare-conference 2019-06-03T10:20:28-04:00 0.5 https://investor.amarincorp.com/events/event-details/goldman-sachs-40th-annual-global-healthcare-conference 2019-06-04T09:09:27-04:00 0.5 https://investor.amarincorp.com/events/event-details/2019-bmo-prescription-success-healthcare-conference 2019-11-05T08:40:14-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q2-results-conference-call 2019-08-21T09:08:34-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-investor-update 2019-08-08T18:04:29-04:00 0.5 https://investor.amarincorp.com/events/event-details/citis-14th-annual-biotech-conference 2019-11-04T19:19:47-05:00 0.5 https://investor.amarincorp.com/events/event-details/hc-wainwright-21st-annual-global-investment-conference 2019-11-04T19:19:21-05:00 0.5 https://investor.amarincorp.com/events/event-details/august-8th-conference-call 2019-10-04T16:18:28-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q3-results-conference-call-2 2019-11-04T18:20:08-05:00 0.5 https://investor.amarincorp.com/events/event-details/aha-investor-webcast 2019-11-04T19:22:43-05:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-2019-london-healthcare-conference 2019-11-11T11:04:09-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-receives-fda-approval-vascepar-icosapent-ethyl-reduce-cardiovascular 2019-12-13T17:37:05-05:00 0.5 https://investor.amarincorp.com/events/event-details/38th-annual-jp-morgan-healthcare-conference 2020-01-06T11:53:40-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q4-results-conference-call-0 2020-02-25T14:41:50-05:00 0.5 https://investor.amarincorp.com/events/event-details/9th-annual-svb-leerink-global-healthcare-conference 2020-02-26T08:14:49-05:00 0.5 https://investor.amarincorp.com/events/event-details/cowen-and-companys-40thannual-health-care-conference 2020-02-26T08:12:59-05:00 0.5 https://investor.amarincorp.com/events/event-details/investor-call-discussing-acc 2020-03-29T19:40:04-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q2-2020-results-conference-call 2020-08-04T07:14:41-04:00 0.5 https://investor.amarincorp.com/events/event-details/2020-cantor-virtual-global-healthcare-conference 2020-09-09T11:40:45-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q3-2020-results-conference-call 2021-04-20T09:55:50-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-virtual-london-healthcare-conference 2020-11-15T16:58:27-05:00 0.5 https://investor.amarincorp.com/events/event-details/stifel-2020-virtual-healthcare-conference 2020-11-11T16:43:10-05:00 0.5 https://investor.amarincorp.com/events/event-details/piper-sandlers-annual-healthcare-conference-virtual 2020-11-24T10:50:58-05:00 0.5 https://investor.amarincorp.com/events/event-details/nla-scientific-sessions-2020-late-breakers-discussion 2020-12-17T10:46:21-05:00 0.5 https://investor.amarincorp.com/events/event-details/39th-annual-jp-morgan-healthcare-conference 2021-01-04T08:34:03-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q4-and-full-year-2020-conference-call 2021-02-17T08:19:05-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-first-quarter-2021-results 2021-06-02T08:16:10-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-virtual-healthcare-conference 2021-06-02T08:13:21-04:00 0.5 https://investor.amarincorp.com/events/event-details/goldman-sachs-42nd-annual-global-healthcare-conference 2021-06-29T17:08:06-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-second-quarter-2021-results 2021-08-04T19:08:43-04:00 0.5 https://investor.amarincorp.com/events/event-details/h-c-wainwright-23rd-annual-global-investment-conference 2021-09-13T09:44:54-04:00 0.5 https://investor.amarincorp.com/events/event-details/cantor-fitzgerald-global-healthcare-conference-2021 2021-09-14T10:20:51-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-third-quarter-2021-results 2021-11-03T01:59:20-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-2021-london-healthcare-conference 2021-11-11T10:50:24-05:00 0.5 https://investor.amarincorp.com/events/event-details/piper-sandler-33rd-annual-virtual-healthcare-conference 2021-11-11T10:49:50-05:00 0.5 https://investor.amarincorp.com/events/event-details/40th-annual-jp-morgan-healthcare-conference 2022-01-05T08:35:01-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-q4-and-full-year-2021-conference-call 2022-04-20T10:55:19-04:00 0.5 https://investor.amarincorp.com/events/event-details/cowen-42nd-annual-health-care-conference 2022-04-20T10:56:49-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-first-quarter-2022-results 2022-05-04T07:50:30-04:00 0.5 https://investor.amarincorp.com/events/event-details/hc-wainwright-global-investment-conference 2022-05-12T08:50:03-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-healthcare-conference 2022-05-12T08:51:08-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-second-quarter-2022-results 2022-08-03T07:02:37-04:00 0.5 https://investor.amarincorp.com/events/event-details/hc-wainwright-24th-annual-global-investment-conference 2022-09-12T09:46:26-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-third-quarter-2022-results 2023-07-18T15:20:29-04:00 0.5 https://investor.amarincorp.com/events/event-details/aha-2022-data-highlights-kol-perspectives-webinar 2023-07-18T14:54:44-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-london-healthcare-conference-0 2023-07-18T14:55:47-04:00 0.5 https://investor.amarincorp.com/events/event-details/jp-morgan-healthcare-conference 2023-07-18T15:21:57-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-board-and-management-webcast 2023-07-18T15:01:26-04:00 0.5 https://investor.amarincorp.com/events/event-details/svb-securities-global-biopharma-conference 2023-07-18T15:23:15-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-fourth-quarter-2022-results 2023-07-18T15:24:14-04:00 0.5 https://investor.amarincorp.com/events/event-details/cowen-annual-health-care-conference 2023-07-18T15:04:49-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-first-quarter-2023-results 2023-07-18T15:24:54-04:00 0.5 https://investor.amarincorp.com/events/event-details/jefferies-healthcare-conference-0 2023-07-18T15:19:32-04:00 0.5 https://investor.amarincorp.com/events/event-details/goldman-sachs-44th-annual-global-healthcare-conference 2023-07-18T15:07:38-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-investor-conference-call 2023-07-18T17:05:06-04:00 0.5 https://investor.amarincorp.com/events/event-details/2023-cantor-global-healthcare-conference 2023-09-12T08:02:51-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporation-third-quarter-2023-results 2023-10-19T08:00:29-04:00 0.5 https://investor.amarincorp.com/events/event-details/42nd-annual-jp-morgan-healthcare-conference 2024-01-09T17:17:59-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-fourth-quarter-and-full-year-2023-results 2024-02-15T08:01:04-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-first-quarter-2024-results 2024-04-15T08:02:06-04:00 0.5 https://investor.amarincorp.com/events/event-details/hc-wainwright-2nd-annual-bioconnect-investor-conference 2024-05-13T10:24:02-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-second-quarter-2024-results 2024-07-17T08:02:01-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-third-quarter-2024-results 2024-10-01T08:03:31-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-virtual-analyst-investor-day-2024 2024-10-01T08:03:25-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-fourth-quarter-full-year-2024-results 2025-04-30T07:53:58-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-first-quarter-2025-results 2025-05-07T08:10:50-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-investor-conference-call-0 2025-06-24T07:54:14-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-second-quarter-2025-results 2025-07-30T07:11:21-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-third-quarter-2025-results 2025-11-07T08:29:32-05:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-fourth-quarter-full-year-2025-results 2026-04-08T13:42:12-04:00 0.5 https://investor.amarincorp.com/events/event-details/amarin-corporations-first-quarter-2026-results 2026-04-15T08:05:06-04:00 0.5 https://investor.amarincorp.com/press-releases 2025-02-24T09:59:04-05:00 0.8 https://investor.amarincorp.com/email-alerts 2025-02-21T10:36:40-05:00 0.8 https://investor.amarincorp.com/sec-filings 2025-02-25T14:30:21-05:00 0.8 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-appoints-colin-w-stewart-president-and-chief 2010-08-30T11:02:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-q2-2010-results 2010-09-01T11:29:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-amr101-pivotal-phase-3-marine-clinical-trial-completes 2010-09-01T11:33:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-host-investor-conference-call-tuesday-august 2010-09-01T11:41:33-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-canaccord-genuity-global-growth-conference 2010-09-01T11:56:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences 2010-09-01T12:00:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-appoints-industry-veteran-joseph-zakrzewski 2010-09-03T02:43:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corp-first-small-biopharmaceutical-company-join-safe 2010-09-03T02:45:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-john-f-thero-chief-financial-officer 2010-09-03T02:46:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-medpace-cro-two-phase-3-cardiovascular-trials 2010-09-03T02:47:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-completion-70-million-private-placement 2010-09-03T02:48:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-changes-its-board-and-management-team 2010-09-03T02:49:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-70-million-private-placement 2010-09-03T02:50:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-extension-nasdaq-file-its-2008-annual-report 2010-09-03T02:51:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-extension-bridge-financing 2010-09-03T02:52:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-30-million-bridge-financing 2010-09-03T02:53:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-revision-non-binding-term-sheet-private 2010-09-03T02:54:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-special-protocol-assessment-agreement-fda-phase 2010-09-03T02:55:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-nasdaq-notification-related-late-filing-2008 2010-09-03T02:56:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-signing-non-binding-term-sheet-private 2010-09-03T02:57:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-preliminary-unaudited-financial-results-six-and 2010-09-03T02:58:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-preliminary-unaudited-financial-results-six-and-0 2010-09-03T03:07:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-results-exploratory-phase-2a-study-en101 2010-09-03T03:09:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-26-million-bridge-financing 2010-09-03T03:09:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-special-protocol-assessment-agreement-fda-0 2010-09-03T03:10:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-ubs-life-sciences-conference 2010-09-16T05:04:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-newsmakers-biotech-industry-conference 2010-10-18T03:31:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-oppenheimer-co-inc-annual-healthcare-conference 2010-10-28T03:35:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-host-investor-conference-call-wednesday 2010-11-09T07:55:10-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-announces-senior-management-changes 2010-11-10T02:05:41-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2010-financial-results-and 2010-11-10T02:10:33-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-q1-2010-results 2010-11-12T05:33:53-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-host-investor-conference-call-thursday-may-13 2010-11-12T05:55:25-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-deutsche-bank-securities-health-care-conference 2010-11-12T06:00:34-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cowen-and-company-healthcare-conference 2010-11-12T06:05:28-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-12th-annual-bio-ceo-investor-conference 2010-11-12T06:09:14-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-jan-van-heek-non-executive-director 2010-11-12T06:59:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-2009-year-end-review-shareholders 2010-11-12T11:45:47-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-announces-first-patients-enrolled-two-phase-3 2010-11-12T11:53:57-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notice-annual-general-meeting 2010-11-12T11:58:22-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-marketing-authorization-application-amr101-treat 2010-11-12T12:02:40-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cowen-company-29th-annual-health-care-conference 2010-11-12T12:05:33-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-11th-annual-bio-ceo-investor-conference 2010-11-12T12:16:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-lazard-capital-markets-annual-healthcare 2010-11-15T02:33:25-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-appoints-kristine-peterson-board-directors 2010-11-18T02:03:42-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-host-conference-call-830-am-est-november-29-2010-discuss 2010-11-26T11:18:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-amr101-meets-pivotal-phase-3-study-endpoints-highly 2010-11-29T01:03:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-canaccord-genuity-cardiovascular-diabetes-obesity 2010-12-03T06:03:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-completes-patient-randomization-phase-3-anchor-trial 2010-12-16T02:04:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-29th-annual-jp-morgan-healthcare-conference 2011-01-05T02:33:41-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-proposed-public-offering-american-depositary 2011-01-05T11:51:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-prices-public-offering-american-depositary-shares 2011-01-06T04:04:35-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-underwriters-exercise-over-allotment-option 2011-01-07T04:03:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-successful-completion-offering-american 2011-01-11T09:33:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-2010-year-end-review-shareholders 2011-01-31T04:04:31-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-appoints-industry-veteran-paul-e-huff-chief 2011-02-02T01:03:35-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-leerink-swann-hot-topics-therapeutics-roundtable 2011-02-07T03:04:36-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-0 2011-02-22T03:04:51-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-1 2011-03-08T11:33:27-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-year-end-and-q4-2010-results 2011-03-16T14:42:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-10th-annual-needham-healthcare-conference 2011-03-31T03:33:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/phase-3-marine-trial-data-be-presented-may-national-lipid 2011-04-05T04:04:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-amr101-phase-3-anchor-trial-meets-all-primary-and 2011-04-17T22:03:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-deutsche-bank-26th-annual-healthcare-conference 2011-04-26T04:05:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2011-results 2011-05-09T23:03:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sponsored-posters-be-presented-today-national-lipid 2011-05-19T04:54:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/additional-detail-successful-marine-phase-iii-trial-be-presented 2011-05-19T04:57:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-global-supply-network-amr101 2011-05-30T22:03:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2011-global-healthcare-conference 2011-06-01T03:03:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-completes-all-non-clinical-work-amr101-nda-submission 2011-07-06T23:03:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-successfully-completes-all-remaining-clinical-studies 2011-08-01T04:03:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/phase-3-anchor-and-marine-trial-data-be-presented-november 2011-08-04T04:04:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-q2-2011-results-conference-call 2011-08-08T03:08:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-2011-canaccord-genuity-growth-conference 2011-08-08T03:15:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2011-results 2011-08-09T13:06:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-agreement-fda-special-protocol-assessment 2011-08-10T00:03:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-wedbush-securities-life-sciences-management 2011-08-12T10:45:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/data-amarins-amr101-phase-3-marine-trial-be-presented-european 2011-08-25T04:03:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-successful-marine-phase-3-clinical-trial 2011-09-01T01:00:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-ubs-global-life-sciences-conference 2011-09-19T03:03:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-nda-submission-amr101-treatment-patients-very 2011-09-26T00:03:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-ring-nasdaq-closing-bell 2011-10-31T12:12:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-q3-2011-results-conference-call 2011-11-03T03:04:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2011-results 2011-11-07T13:36:08-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-2 2011-11-10T11:18:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-phase-3-marine-and-anchor-study-data-be-presented 2011-11-14T02:36:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-phase-3-marine-study-results-presented-american-heart 2011-11-15T11:15:19-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-phase-3-anchor-study-results-presented-american-heart 2011-11-16T02:36:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-added-nasdaq-biotechnology-index 2011-11-21T02:03:37-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-resignation-david-feigal-board-directors 2011-11-25T02:00:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-acceptance-filing-amr101-nda 2011-11-25T02:03:10-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-dosing-first-patient-cardiovascular-outcomes 2011-12-07T01:03:25-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-addition-industry-veteran-patrick-osullivan 2011-12-14T04:06:19-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-appointment-joseph-t-kennedy-general-counsel 2011-12-19T11:42:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-commences-2012-letter-shareholders 2012-01-03T01:03:25-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-plc-announces-offering-150-million 2012-01-03T11:09:17-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-plc-announces-pricing-150-million 2012-01-04T04:30:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-leerink-swann-2012-global-healthcare-conference 2012-02-07T03:05:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-advisory-committee-will-not-be-scheduled 2012-02-13T03:04:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-appoints-dr-steven-ketchum-head-research-and 2012-02-16T03:04:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-citi-2012-global-healthcare-conference 2012-02-22T03:03:47-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-year-end-2011-results-and-host 2012-02-22T03:03:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-year-end-2011-financial 2012-02-29T11:07:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-24th-annual-roth-oc-growth-stock-conference 2012-03-06T03:04:32-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-amr101 2012-03-20T07:39:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2012-financial-results-and-host 2012-05-01T12:12:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2012-financial-results-and-provides 2012-05-08T12:04:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/data-amarins-amr101-be-presented-national-lipid-association-2012 2012-05-24T12:24:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-us-patent-issuance-amr101 2012-05-29T03:30:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2012-global-healthcare-conference 2012-05-29T12:33:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amr101-phase-3-study-data-patients-diabetes-mellitus-type-2-be 2012-06-04T03:03:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notice-allowance-additional-us-patent-covering 2012-07-02T02:03:14-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-publication-anchor-phase-3-clinical-trial 2012-07-24T04:33:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-notice-intention-grant-european-patent 2012-07-25T03:27:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-approval-vascepatm-icosapent-ethyl-capsules 2012-07-26T13:45:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2012-financial-results-and-host 2012-07-31T04:33:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2012-financial-results-and 2012-08-08T12:03:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-additional-publication-marine-phase-3-clinical 2012-08-28T12:03:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application 2012-09-04T04:42:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowances-us-applications 2012-09-05T04:36:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-0 2012-09-06T04:36:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-1 2012-09-10T04:33:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-issuance-us-patents-8793727-and-8293728 2012-10-23T03:33:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-us-patent-8298554-issuance-vascepatm 2012-10-30T03:33:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2012-financial-results-and-host 2012-11-01T14:00:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2012-financial-results-and-provides 2012-11-08T11:06:36-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-us-patent-8314086-issuance-vascepar 2012-11-20T02:33:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-2 2012-11-20T10:57:51-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-3 2012-11-26T02:30:30-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-us-patent-8318715-issuance-vascepar 2012-11-27T02:33:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-us-patent-8324195-issuance-vascepar 2012-12-04T02:33:16-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-100-million-non-equity-financing-and-vascepa 2012-12-06T11:03:33-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-additional-vascepar-icosapent-ethyl-supplier 2012-12-11T02:33:14-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/david-stack-appointed-amarin-board-directors 2012-12-12T02:33:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-4 2012-12-13T02:33:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-completion-dosing-fixed-dose-combination-study 2012-12-17T02:33:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-submission-supplemental-new-drug-application 2025-04-29T15:45:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-submission-supplemental-new-drug-application-0 2013-01-02T02:33:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-31st-annual-jp-morgan-healthcare-conference 2013-01-02T12:03:22-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-5 2013-01-11T02:33:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-publication-additional-inflammatory-marker-data 2013-01-22T02:33:24-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-first-notification-us-patent-allowance-based 2013-01-23T06:30:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-market-introduction-vascepar-icosapent-ethyl 2013-01-24T02:33:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-two-additional-patent-allowances 2013-01-31T02:33:30-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-additional-us-patent-allowance-us 2013-02-01T02:33:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-6 2013-02-07T02:35:27-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-leerink-swann-global-healthcare-conference-2013 2013-02-07T11:09:44-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-7 2013-02-12T01:03:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-citi-2013-global-healthcare-conference 2013-02-21T11:10:42-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-year-end-2012-results-and-host 2013-02-22T11:06:14-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-submission-supplemental-new-drug-application-1 2013-02-26T00:03:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-year-end-2012-financial 2013-02-28T11:06:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-8 2013-03-07T03:00:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-new-clinical-data-showing-significant 2013-04-08T02:03:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-approval-supplemental-new-drug-application 2013-04-18T02:03:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-acceptance-supplemental-new-drug 2013-04-23T02:03:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-approval-supplemental-new-drug-application-basf 2013-04-30T02:03:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2013-results-and-host-conference 2013-05-03T12:03:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2013-financial-results-and-provides 2013-05-20T09:53:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowance-us-application-9 2013-05-22T02:03:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-additional-effects-vascepar-lipoprotein 2013-05-30T02:03:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2013-global-healthcare-conference 2013-05-30T12:06:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-informed-fda-october-16th-advisory-committee-date 2013-06-19T04:00:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-positive-results-phase-1-clinical-trial 2013-06-21T02:03:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-public-offering-american-depositary-shares 2013-07-08T12:45:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-completion-offering-american-depositary-shares 2013-07-12T12:03:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2013-results-and-host-conference 2013-08-02T12:06:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2013-financial-results-and 2013-08-08T12:06:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-canaccord-genuity-33rd-annual-growth-conference 2013-08-13T02:03:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-submission-supplemental-new-drug-application-2 2013-08-26T02:03:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-30th-patent-vascepar 2013-09-09T03:21:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-2013-aegis-capital-healthcare-conference 2013-09-18T02:12:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-enrollment-reduce-it-cardiovascular-outcomes 2013-09-25T02:03:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-informed-fda-october-16th-advisory-committee-meeting-will 2013-10-03T04:18:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-host-conference-call-october-16-2013-discuss-results-fda 2013-10-09T04:33:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-nasdaq-amrn-stock-trading-halted-today-fda 2013-10-16T00:12:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-advisory-committee-outcome-use-vascepa 2013-10-16T12:21:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-plans-reduce-expenses-decreasing-staff 2013-10-22T12:04:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2013-results-and-host-conference 2013-10-31T12:08:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2013-financial-results-and-provides 2013-11-07T11:12:35-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-notification-patent-allowances-us-0 2013-12-02T01:03:26-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-leadership-changes 2013-12-16T04:04:49-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-fda-notification-action-anchor-snda-review-will 2013-12-20T01:03:19-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-review-division-response-anchor-spa 2014-01-15T11:06:45-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-review-division-response-anchor-spa-0 2014-01-20T20:03:21-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-promotion-aaron-berg-senior-vice-president 2014-02-04T01:03:28-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-2014-leerink-global-healthcare-conference 2014-02-06T01:33:40-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-award-three-year-exclusivity-vascepar 2014-02-21T11:03:22-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-year-end-2013-results-and-host 2014-02-24T01:03:38-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-year-end-2013-financial 2014-02-27T11:05:23-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-kowa-pharmaceuticals-america-inc-announce-us-co 2014-03-31T12:33:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-presentation-new-marine-and-anchor-post-hoc 2014-05-02T04:03:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2014-results-and-host-conference 2014-05-05T04:05:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2014-financial-results-and-provides 2014-05-09T03:03:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-private-exchange-transactions-regarding 2014-05-15T01:00:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2014-global-healthcare-conference 2014-05-29T04:04:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-goldman-sachs-2014-global-healthcare-conference 2014-06-04T04:04:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-publication-case-study-results-describing 2014-06-11T03:00:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/rick-harrison-televisions-pawn-starsr-discusses-his-revelations 2014-06-25T02:30:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2014-results-and-host-conference 2014-08-05T03:05:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2014-financial-results-and 2014-08-07T12:05:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-rodman-renshaw-2014-global-investment-conference 2014-09-03T03:00:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-update-anchor-trial-spa-agreement-rescission 2014-09-12T05:00:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reaffirms-its-mission-improve-patient-care-commitment 2014-09-15T21:00:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2014-results-and-host-conference 2014-10-30T03:05:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-host-third-quarter-2014-earnings-conference-call-and 2014-11-05T11:57:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2014-financial-results-and-provides 2014-11-06T11:00:59-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/rick-harrison-televisions-pawn-starsr-takes-his-patient-care 2014-11-13T02:01:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-presentation-marine-and-anchor-analyses 2014-11-17T04:00:53-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-25th-annual-oppenheimer-healthcare-conference 2014-12-04T02:00:36-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-33rd-annual-jp-morgan-healthcare-conference 2015-01-05T02:01:08-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-year-end-2014-results-and-host 2015-02-23T11:30:33-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-eddingpharm-announce-agreement-develop-and 2015-02-26T04:18:14-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-host-fourth-quarter-and-fiscal-year-2014-earnings 2015-03-02T11:11:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-year-end-2014-financial 2015-03-03T11:00:34-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-vitro-study-presented-deuel-conference-lipids-suggests 2015-03-04T03:01:47-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-528-million-private-placement 2015-03-06T00:00:16-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-vitro-study-presented-american-college-cardiology-meeting 2015-03-16T12:30:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-non-profit-walk-doc-partner-expand-national-health 2015-04-08T04:05:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2015-results-and-host-conference 2015-05-05T13:01:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2015-financial-results-and-provides 2015-05-08T02:00:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2015-global-healthcare-conference 2015-05-26T13:00:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-granted-summary-judgment-motion-suit-against-fda-seeking 2015-05-28T10:30:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-vitro-eicosapentaenoic-acid-study-data-presented-june-6 2015-06-08T03:01:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-vitro-eicosapentaenoic-acid-study-data-be-presented-national 2015-06-11T03:01:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2015-results-and-host-conference 2015-07-30T03:02:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-upcoming-presentations-two-eicosapentaenoic 2015-07-31T03:00:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2015-financial-results-and 2015-08-06T12:03:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/first-amendment-decision-win-amarin-and-physician-plaintiffs 2015-08-07T06:50:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-promotes-joseph-t-kennedy-executive-vice-president 2015-08-11T03:00:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-encore-presentation-results-apolipoprotein-c 2015-08-27T03:00:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-rodman-renshaw-2015-global-investment-conference 2015-09-02T03:00:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2015-results-and-host-conference 2015-10-28T03:02:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2015-financial-results-and-provides 2015-11-04T02:00:32-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/epa-therapy-added-statin-therapy-showed-coronary-plaque 2015-11-09T03:09:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-agreement-purchase-162-million-its-existing 2015-11-20T01:00:13-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-27th-annual-piper-jaffray-healthcare-conference 2015-11-24T01:00:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-oppenheimer-co-inc-26th-annual-healthcare 2015-12-02T01:00:10-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-added-nasdaq-biotechnology-index-0 2015-12-14T01:00:02-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-preliminary-2015-net-product-sales-and-provides 2016-01-11T01:59:49-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-craig-b-granowitz-chief-medical-officer-and 2016-01-21T02:57:38-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/request-continued-stay-court-proceedings-submitted-amarin-first 2016-02-17T03:02:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2015-results-and-host 2016-02-18T03:00:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-year-end-2015-financial 2016-02-25T02:00:45-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-right-promote-vascepar-label-affirmed-under-first 2016-03-08T11:13:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/court-approves-proposed-settlement-terms-amarin-first-amendment 2016-03-09T07:31:56-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reaches-target-enrollment-cardiovascular-outcomes-study 2016-03-31T03:00:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-clinical-and-pre-clinical-data-presented-american-college 2016-04-04T03:00:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2016-results-and-host-conference 2016-04-28T03:43:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2016-financial-results-and-provides 2016-05-05T03:01:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-and-eicosapentaenoic-acid-epa-data-be 2016-05-11T03:30:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-significant-reductions-key-lipid 2016-05-20T06:49:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-new-chemical-entity-market-exclusivity 2016-05-31T09:29:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2016-global-healthcare-conference 2016-06-01T04:00:04-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-data-be-presented-american-diabetes 2016-06-06T03:32:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-significant-reductions 2016-06-11T07:01:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-michael-w-kalb-chief-financial-officer 2016-06-30T03:29:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cantor-fitzgeralds-2nd-annual-healthcare 2016-07-06T04:01:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2016-results-and-host-conference 2016-07-28T02:59:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-fda-reaffirm-concurrence-reduce-it-through-special 2016-08-04T01:45:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2016-financial-results-and 2016-08-04T02:56:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-proposed-public-offering-american-depositary-0 2016-08-10T12:11:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-prices-public-offering-american-depositary-shares-0 2016-08-11T05:19:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-underwriters-exercise-option-purchase 2016-08-15T03:31:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-mandatory-exchange-exchangeable-senior-notes 2016-08-26T12:19:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-randomizes-final-patient-reduce-it-cardiovascular 2016-08-31T03:32:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-rodman-renshaw-18th-annual-global-investment 2016-09-07T03:31:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-reduce-it-cardiovascular-outcomes-study-vascepa-continue 2016-09-12T01:01:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/pure-epa-vascepar-now-available-new-smaller-half-gram-capsule 2016-10-25T03:01:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2016-results-and-host-conference 2016-10-27T12:56:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2016-financial-results-and-provides 2016-11-03T01:32:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2016-london-healthcare-conference 2016-11-11T05:28:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/pure-epa-vascepar-icosapent-ethyl-showed-reductions-potentially 2016-11-14T14:32:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-contractual-reminder-optional-put-holders-151 2016-12-16T11:32:02-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-2016-results-and-2017-outlook 2017-01-05T11:02:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-debt-restructuring-and-related-private 2017-01-20T01:00:46-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-leerink-partners-6th-annual-global-healthcare 2017-02-09T02:52:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2016-results-and-host 2017-02-22T03:00:58-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-record-fourth-quarter-and-full-year-2016 2017-02-28T01:02:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-publication-reduce-it-cardiovascular-outcomes 2017-03-15T05:58:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-ceo-john-thero-chair-american-heart 2017-03-21T04:42:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reaches-onset-approximately-80-target-aggregate-number 2017-03-21T04:53:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2017-results-and-host-conference 2017-04-25T12:30:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2017-financial-results-and-provides 2017-05-03T01:02:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-expanded-research-relationships-and-studies 2017-05-18T02:00:33-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2017-global-healthcare-conference 2017-06-01T02:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-reductions-potentially 2017-06-12T03:00:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2017-results-and-host-conference 2017-07-26T12:30:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2017-financial-results-and 2017-08-02T01:32:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-reduce-it-cardiovascular-outcomes-study-vascepa-0 2017-08-14T02:01:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-rodman-renshaws-global-investment-conference 2017-09-06T02:02:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-mark-w-salyer-new-position-chief-commercial 2017-09-13T02:02:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cantor-global-healthcare-conference 2017-09-20T12:32:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-hls-therapeutics-announce-agreement-commercialize 2017-09-25T02:02:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2017-results-and-host-conference 2017-10-25T02:00:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sponsors-multiple-scientific-study-presentations 2017-11-01T14:06:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2017-financial-results-and-provides 2017-11-02T12:03:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-london-healthcare-conference 2017-11-07T01:02:03-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/real-world-data-analysis-shows-high-triglyceride-levels-are 2017-11-13T01:02:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-reductions-potentially-0 2017-11-13T11:30:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/real-world-data-analysis-shows-persistent-hypertriglyceridemia 2017-11-14T11:30:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-36th-annual-jp-morgan-healthcare-conference-san 2017-12-18T11:32:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-reduce-it-cardiovascular-outcomes-study-final 2017-12-19T01:00:27-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-2017-results-and-provides-2018 2018-01-04T11:32:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-commencement-vascepar-clinical-development 2018-01-17T01:02:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-reduce-it-cardiovascular-outcomes-study-reaches-90-mark 2018-01-23T01:00:28-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-proposed-public-offering-american-depositary-1 2018-01-29T11:02:02-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-prices-public-offering-american-depositary-shares-1 2018-01-30T04:00:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2017-results-and-host 2018-02-20T11:30:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-record-fourth-quarter-and-full-year-2017 2018-02-27T00:02:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sponsors-multiple-scientific-presentations-scheduled-2018 2018-02-28T00:02:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-start-final-clinical-site-visits-reduce-it 2018-03-01T00:02:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-closing-underwriters-purchase-additional-shares 2018-03-05T11:36:00-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-reductions-potentially-1 2018-03-12T12:30:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/real-world-data-supports-association-between-elevated 2018-03-12T12:30:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-first-middle-east-approval-vascepar 2018-03-21T01:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-commemorates-national-triglycerides-day-march-28 2018-03-27T12:30:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-hc-wainwright-annual-global-life-sciences 2018-03-28T12:32:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sponsors-two-scientific-presentations-scheduled-national 2018-03-29T01:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-reduce-it-cardiovascular-outcomes-study-reaches-100-mark 2018-04-04T01:02:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-updates-first-quarter-revenue-guidance-reiterates-full 2018-04-04T01:16:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-reductions-potentially-2 2018-04-12T01:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sponsors-three-scientific-presentations-scheduled 2018-04-12T12:32:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-promotion-aaron-berg-position-chief-commercial 2018-04-23T01:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2018-results-and-host-conference 2018-04-26T01:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2018-financial-results-and-provides 2018-05-02T01:02:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-global-healthcare-conference 2019-09-26T15:41:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-patent-litigation-settlement-agreement-teva 2019-09-26T15:40:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sponsors-three-scientific-presentations-scheduled-0 2019-09-26T15:40:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-mochida-announce-collaboration-future-development-epa 2019-09-26T15:39:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/real-world-data-supports-association-between-high-triglyceride 2019-09-26T15:39:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-last-patient-study-visit-has-occurred-important 2019-09-26T15:38:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2018-results-and-host-conference 2019-09-26T15:38:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-approval-vascepar-united-arab-emirates 2019-09-26T15:38:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2018-financial-results-and 2019-09-26T15:37:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/real-world-data-supports-association-between-elevated-0 2019-09-26T15:36:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-reduce-ittm-clinical-study-now-positioned-be-next-large 2019-09-26T15:36:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-ittm-trial-primary-results-accepted-presentation-2018 2019-09-26T15:35:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-ittm-cardiovascular-outcomes-study-vascepar-icosapent 2019-09-26T15:35:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cantor-global-healthcare-conference-0 2019-09-26T15:34:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-mandatory-exchange-exchangeable-senior-notes-0 2019-09-26T15:34:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2018-results-and-host-conference 2019-09-26T15:33:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-schedules-webcast-discussion-primary-reduce-ittm-trial 2019-09-26T15:33:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2018-financial-results-and-provides 2019-09-26T15:32:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2018-london-healthcare-conference 2019-09-26T15:31:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-26-reduction-key-secondary-composite 2019-09-26T15:30:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-evercore-isi-healthconx-conference 2019-09-26T15:30:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-proposed-public-offering-american-depositary-2 2019-09-26T15:29:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-prices-public-offering-american-depositary-shares-2 2019-09-26T15:29:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-fireside-chat-citis-2018-global-healthcare 2019-09-26T15:28:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-37th-annual-jp-morgan-healthcare-conference 2019-09-26T15:28:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-2018-results-and-2019-outlook 2019-09-26T15:28:04-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-ittm-trial-data-showing-total-reduction-ischemic 2019-09-26T15:27:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-8th-annual-svb-leerink-global-healthcare 2019-09-26T15:26:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2018-results-and-host 2019-09-26T15:25:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-record-fourth-quarter-and-full-year-2018 2019-09-26T15:24:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/important-new-data-vascepar-icosapent-ethyl-reduce-ittm-trial-be 2019-09-26T15:23:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cowens-39th-annual-health-care-conference 2019-09-26T15:23:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/high-risk-atherosclerotic-cardiovascular-events-projected-people 2019-09-26T15:22:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-showed-30-reduction-total 2019-09-26T15:22:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/additional-real-world-data-show-significant-risk-increase 2019-09-26T15:21:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cardiovascular-risk-multiple-triglyceride-thresholds-highlighted 2019-09-26T15:21:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-updates-american-diabetes-associationsr-2019-standards 2019-09-26T15:20:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-submits-supplemental-new-drug-application-snda-us-fda 2019-09-26T15:20:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-granted-priority-review-status-health-canada-new-drug 2019-09-26T15:17:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2019-results-and-host-conference 2019-04-24T06:00:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-drug-submission-filed-vascepar-health-canada 2019-04-29T06:00:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2019-financial-results-and-provides 2019-05-01T05:00:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-be-featured-multiple-scientific-sessions-national-lipid 2019-05-16T16:16:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/us-fda-grants-priority-review-vascepar-icosapent-ethyl 2019-05-29T06:00:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2019-healthcare-conference 2019-05-30T05:00:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/pharmaceutical-industry-veteran-gwen-fisher-joins-amarin-lead 2019-05-30T07:00:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-goldman-sachs-40th-annual-global-healthcare 2019-06-04T06:00:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/correcting-and-replacing-amarin-present-findings-regarding 2019-06-07T11:39:04-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-2019-bmo-prescription-success-healthcare 2019-06-18T07:00:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-john-thero-awarded-nj-ey-entrepreneur-yearr-2019-award 2019-06-21T13:39:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-mid-2019-update-including-commercialization 2019-07-02T06:00:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-400000000-public-offering-american-depositary 2019-07-17T16:01:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-prices-public-offering-american-depositary-shares-3 2019-07-18T23:47:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2019-results-and-host-conference 2019-07-24T06:00:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-underwriters-full-exercise-option-purchase 2019-07-29T17:17:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2019-financial-results-and 2019-07-31T05:00:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-fda-notification-advisory-committee-meeting 2019-08-08T16:30:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-fireside-chat-citis-14th-annual-biotech 2019-08-21T06:00:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-overview-growing-global-attention-reduce-ittm 2019-08-27T06:00:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-hc-wainwright-21st-annual-global-investment 2019-08-28T06:00:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-2019-updates-european-society-cardiologys-and-european 2019-09-03T06:00:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/national-lipid-associations-new-position-statement-use-icosapent 2019-09-16T06:00:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduction-first-and-total-ischemic-events-icosapent-ethyl-across 2019-10-08T13:38:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reply-letters-chan-l-n-and-borghi-c-fogacci-f-cicero-afg 2019-10-08T14:53:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-reduces-atherogenic-markers-high-risk-statin 2019-09-27T15:49:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-cantor-global-healthcare-conference 2019-09-23T16:15:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cardiovascular-risk-reduction-icosapent-ethyl 2019-09-27T10:07:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/elevated-triglycerides-150-mgdl-and-high-triglycerides-200-499 2020-05-27T11:51:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-elevated-triglycerides-increased-cardiovascular-risk 2019-09-27T16:37:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-residual-cardiovascular-risk-statin-treated-patients 2019-09-30T09:09:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-total-ischemic-events-reduce-it 2019-10-09T08:26:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cardiovascular-risk-reduction-icosapent-ethyl-0 2019-09-27T15:08:03-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester 2019-09-27T16:01:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-effects-fatty-acid-profiles-statin-treated 2019-09-27T16:05:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/lipid-effects-icosapent-ethyl-women-diabetes-mellitus-and 2019-10-10T10:45:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/knowledge-perceptions-and-patterns-fish-oil-use-cardiac-patients 2020-06-24T13:23:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduction-total-ischemic-events-reduction-cardiovascular-events 2020-06-24T14:04:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/long-term-statin-persistence-poor-among-high-risk-patients 2020-06-24T14:06:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/burden-atherosclerotic-cardiovascular-disease-risk-persons 2020-06-24T14:07:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/hypertriglyceridemia-associated-increased-risk-peripheral 2019-09-27T16:41:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/economic-burden-hypertriglyceridemia-among-us-adults-diabetes-or 2019-09-27T16:45:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/dyslipidemia-management-diabetes 2019-09-27T16:54:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/predicting-risk-incident-heart-failure-omega-3-fatty-acids-mesa 2019-09-27T16:57:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-insights-mechanisms-action-omega-3-fatty-acids 2019-09-27T17:16:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/unmet-need-adjunctive-dyslipidemia-therapy-hypertriglyceridemia 2019-10-09T08:27:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-vascepa-icosapent-ethyl-progression-coronary 2019-09-27T17:23:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/potential-benefits-eicosapentaenoic-acid-atherosclerotic-plaques 2019-09-27T17:26:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/randomized-controlled-trial-eicosapentaenoic-acid-patients 2019-09-27T17:28:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglyceride-rich-lipoproteins-and-atherosclerotic 2019-09-27T17:37:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-vascepa-icosapent-ethyl-progression-coronary-0 2019-09-30T16:33:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/rationale-and-design-reduce-it-reduction-cardiovascular-events 2019-10-01T08:13:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/usefulness-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester 2019-10-10T10:46:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-concentration-and 2019-09-30T16:50:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects 2019-09-30T16:53:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-plasma 2019-09-30T16:56:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-upon 2019-09-30T17:00:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-lipoprotein-particle-concentration-and 2019-09-30T17:05:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-concomitant-icosapent-ethyl-eicosapentaenoic-acid-ethyl 2019-10-10T10:50:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-0 2019-10-10T10:43:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester 2019-10-10T10:47:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/phase-1-study-effect-icosapent-ethyl-warfarin-pharmacokinetic 2019-10-10T10:48:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/pharmacokinetics-eicosapentaenoic-acid-plasma-and-red-blood 2019-10-10T11:03:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-pure-epa-omega-3-fatty-acid-effects-plasma-and 2019-09-30T18:44:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-lipid-and-inflammatory-parameters 2019-09-30T18:50:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-pure-ethyl-ester-eicosapentaenoic-acid-effects 2019-09-30T19:02:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/efficacy-and-safety-eicosapentaenoic-acid-ethyl-ester-amr101 2019-09-30T19:09:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-pure-epa-omega-3-fatty-acid-effects-lipoprotein 2019-09-30T19:12:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-ethyl-ester-amr101-therapy-patients-very 2019-09-30T19:15:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/increased-residual-cardiovascular-risk-us-veterans-and 2020-06-24T15:39:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-risk-factor-coronary-heart-disease-what-measure 2020-06-24T15:27:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-membrane-lipid-oxidation 2020-06-24T15:28:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/long-term-renal-function-worsens-high-cardiovascular-risk 2020-06-24T15:33:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-reduces 2020-06-24T16:24:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-statin-treated 2020-06-24T16:04:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/long-term-statin-persistence-poor-among-high-risk-patients-real 2020-06-25T12:57:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-reduces-potentially-atherogenic-lipid-and 2020-06-25T15:55:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-amr101-pure-eicosapentaenoic-omega-3-fatty-acid-fatty 2020-06-25T16:55:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/long-term-statin-persistence-poor-among-high-risk-patients-0 2020-06-24T16:19:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-between-triglycerides-and-residual-cardiovascular 2020-06-24T16:25:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-inhibits-human-hdl-oxidation 2020-06-24T16:27:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/increased-cardiovascular-risk-patients-diabetes-statin 2020-06-24T16:30:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-and-predictors-residual-hypertriglyceridemia 2020-06-24T16:32:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglyceride-lowering-effects-icosapent-ethyl-pure 2020-08-07T15:48:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-exposure-lowers-triglycerides-without 2020-09-08T15:41:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-highly-purified-eicosapentaenoic-acid 2019-10-03T13:04:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-strong-predictor-risk-heart-failure-multi 2019-10-03T14:27:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibited-oxidized-hdl-induced-loss 2020-02-03T11:27:39-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-oxidation-small-dense-ldl-manner 2019-10-03T15:26:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/potential-electronic-health-record-data-optimize-recruitment 2019-10-03T15:34:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/predictive-modeling-assess-predictors-treatment-success-and 2019-10-03T15:36:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/relationship-between-lipid-levels-and-coronary-atherosclerotic 2019-10-09T08:45:05-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/economic-burden-hypertriglyceridemia-among-us-adults-diabetes-0 2019-10-09T08:45:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-us-adults-triglycerides-135-mgdl-nhanes-2007-2014 2019-10-09T08:58:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-between-lipids-and-coronary-atherosclerotic-plaque 2019-10-09T08:59:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-unlike-arachidonic-acid-maintains-normal 2019-10-09T09:00:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/comparison-atherosclerotic-plaque-characteristics-among-normal 2019-10-08T14:12:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/knowledge-perceptions-and-patterns-fish-oil-use-cardiac-0 2019-10-09T09:02:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/plasma-epa-eicosapentaenoic-acidaa-arachidonic-acid-ratio 2019-10-09T09:03:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/potential-electronic-health-record-data-optimize-recruitment-0 2019-10-09T09:05:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/managing-lipid-triad-improving-physicians-understanding-role 2019-10-03T16:47:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-reduces-potentially-atherogenic-lipid-and-0 2019-10-09T09:06:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-reduces-potentially-atherogenic-lipid-and-1 2019-10-09T09:07:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/omega-3-fatty-acid-treatment-obese-patient-hypertension-and 2019-10-09T09:07:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acidarachidonic-acid-ratio-and-its-clinical 2019-10-08T14:27:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/generalizability-reduce-it-trial-patients-stable-coronary-artery 2019-10-08T14:24:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/national-health-and-nutrition-examination-survey 2019-10-08T14:25:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/increased-residual-cardiovascular-risk-patients-diabetes-and 2019-10-08T14:37:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-us-adults-triglycerides-135-mgdl-nhanes-2007-2014-0 2019-10-08T14:38:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/comparison-medical-care-utilization-and-costs-among-patients 2019-10-08T14:22:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/high-triglycerides-are-associated-increased-cardiovascular 2019-10-08T14:39:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/increased-cardiovascular-risk-hypertriglyceridemic-patients 2019-10-08T14:40:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-improves-endothelial-function-and-nitric 2019-10-08T14:41:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-and-docosahexaenoic-acid-have-distinct 2020-06-25T17:11:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-oxidation-high-density 2019-10-08T14:45:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cardiovascular-disease-and-omega-3s-prescription-products-and 2019-10-08T14:51:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/managing-hypertriglyceridemia-what-can-we-learn-cardiovascular 2020-05-27T12:09:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/can-pleiotropic-effects-eicosapentaenoic-acid-epa-impact 2019-10-08T14:47:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-potential-therapeutic-approach-reduce 2019-10-08T15:16:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/potential-benefits-eicosapentaenoic-acid-atherosclerotic-0 2019-10-09T07:50:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prescription-omega-3-fatty-acid-products-containing-highly 2019-10-09T07:52:14-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/omega-3-fatty-acid-fish-oil-dietary-supplements-contain 2019-10-09T07:54:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-atherosclerosis-and-cardiovascular-outcome-studies 2019-10-09T07:53:46-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-reduces-membrane-fluidity-inhibits 2019-10-09T07:58:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/lipid-effects-switching-prescription-epadha-omega-3-acid-ethyl 2019-10-09T08:00:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/witching-epa-dha-omega-3-acid-ethyl-esters-high-purity-epa 2019-10-09T08:01:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/novel-cost-effectiveness-model-prescription-eicosapentaenoic 2019-10-09T08:02:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-and-triglyceride-rich-lipoproteins-causal-pathway 2019-10-09T08:03:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/improving-lipids-prescription-icosapent-ethyl-after-previous-use 2019-10-09T08:04:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/omega-3-fatty-acid-formulations-cardiovascular-disease-dietary 2019-10-09T08:05:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/editors-roundtable-current-perspectives-triglycerides-and 2019-10-09T08:05:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prescription-omega-3-fatty-acid-products-considerations-patients 2019-10-09T08:06:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-oxidation-apob-containing 2019-10-09T08:07:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/switching-statin-treated-patients-fenofibrate-prescription-omega 2019-10-09T08:07:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-hypertriglyceridaemia-guide-its-use 2019-10-09T08:08:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/history-and-future-omega-3-fatty-acids-cardiovascular-disease 2019-10-09T08:13:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prescription-omega-3-fatty-acid-products-and-dietary-supplements 2019-10-09T08:14:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/comparative-overview-prescription-omega-3-fatty-acid-products 2019-10-09T08:15:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-switching-omega-3-acid-ethyl-esters-icosapent-ethyl 2019-10-09T08:15:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/biologic-plausibility-cellular-effects-and-molecular-mechanisms 2019-10-09T08:16:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/retrospective-case-series-patients-diabetes-or-prediabetes-who 2019-10-09T08:17:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-glucose-induced-membrane 2019-10-09T08:17:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/overview-prescription-omega-3-fatty-acid-products 2019-10-09T08:18:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/retrospective-case-series-lipid-effects-switching-omega-3-fatty 2019-10-09T08:19:04-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/perspectives-new-prescription-omega-3-fatty-acid-icosapent-ethyl 2019-10-09T08:19:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/potential-benefits-icosapent-ethyl-lipid-profile-case-studies 2019-10-09T08:20:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/overview-omega-3-fatty-acid-therapies 2019-10-09T08:21:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/update-marine-omega-3-fatty-acids-management-dyslipidemia-and 2019-10-09T08:21:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-treatment-hypertriglyceridemia 2019-10-09T08:22:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/editors-roundtable-hypertriglyceridemia 2019-10-09T08:23:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-pure-o-3-eicosapentaenoic-acid-ethyl-ester-amr101-management 2019-10-09T08:24:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-eicosapentaenoic-acid-and-docosahexaenoic-acid-low 2019-10-09T08:24:55-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/comparing-eicosapentaenoic-acid-between-plasma-and-serum 2019-10-08T09:37:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/can-pleiotropic-effects-eicosapentaenoic-acid-epa-impact-0 2019-10-08T14:52:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/independent-drug-pricing-assessment-finds-vascepar-icosapent 2019-10-17T09:48:46-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2019-results-and-host-conference 2019-10-24T16:30:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/seven-data-presentations-relevant-vascepar-icosapent-ethyl 2019-11-04T06:00:31-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2019-financial-results-and-provides 2019-11-05T05:00:40-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-inhibits-human-low-density-lipoprotein 2020-02-03T18:15:37-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/residual-hypertriglyceridemia-and-estimated-atherosclerotic 2019-11-08T09:38:22-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-lesson-genetics 2019-11-08T10:03:29-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/does-high-dose-fish-oil-reduce-cardiovascular-events 2019-11-08T10:06:23-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-hypertriglyceridaemia-statin-treated-very-high-risk 2019-11-08T10:10:06-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-2019-london-healthcare-conference 2019-11-11T05:00:21-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-itr-usa-results-prespecified-subgroup-analyses-landmark 2019-11-11T06:30:36-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-analysis-shows-icosapent-ethyl-vascepar-cost-effective-and 2019-11-11T13:19:50-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-plc-nasdaqamrn-stock-trading-halted-today 2019-11-14T06:59:10-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announced-fda-advisory-committee-voted-unanimously-16-0 2019-11-14T17:34:26-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarins-john-thero-awarded-ey-entrepreneur-yearr-2019-life 2019-11-18T12:15:04-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-key-reduce-itr-related-data-presented-american 2019-11-18T17:30:21-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/european-medicines-agency-accepts-review-marketing-authorization 2019-12-02T06:00:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/elevated-triglycerides-150-mgdl-and-high-triglycerides-200-499-0 2020-01-06T13:29:29-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/nathan-d-wong-peter-p-toth-md-phd-ezra-amsterdam-md-behalf 2019-12-11T07:53:10-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-fda-approval-vascepar-icosapent-ethyl-reduce 2019-12-13T16:48:44-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-approved-canada-reduce-risk-cardiovascular-events 2020-01-02T06:00:17-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-38th-annual-jp-morgan-healthcare-conference 2020-01-06T06:00:17-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-update-preliminary-2019-results-and-further 2020-01-07T06:00:31-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-launches-true-your-heart-campaign-educate-people 2020-01-13T06:00:19-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/profound-reductions-first-and-total-cardiovascular-events 2020-06-24T13:54:05-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-usa-results-3146-patients-randomized-united-states 2020-02-03T11:54:51-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/critical-differences-between-dietary-supplement-and-prescription 2020-02-03T12:00:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/risk-cardiovascular-events-patients-hypertriglyceridemia-review 2020-02-03T12:03:38-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-united-states-adults-triglycerides-135-mgdl-nhanes 2020-05-27T12:03:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-icosapent-ethyl-progression-coronary-atherosclerosis 2020-02-03T12:23:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cost-effectiveness-icosapent-ethyl-reduce-it-abstract-presented 2020-06-25T12:38:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/purified-eicosapentaenoic-acid-ameliorates-cardiac-fibrosis-and 2020-02-03T16:21:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/improving-appropriate-use-omega-3-fatty-acids-primary-care 2020-02-03T16:28:05-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-usa-results-3146-patients-drandomized-united-states 2020-02-03T16:33:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/contrasting-effects-eicosapentaenoic-and-arachidonic-acid 2020-02-03T16:46:52-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/many-statin-treated-persons-borderline-triglyceride-levels-are 2020-06-25T12:42:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/primary-results-reduce-it-trial-abstract-19515 2020-02-03T16:52:27-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-unlike-other-omega-3-fatty-acids-inhibits 2020-06-25T12:47:04-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-therapy-associated-decreased-coronary 2020-02-03T18:17:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-honored-bionj-innovator-award-vascepar-development-and 2020-02-06T21:26:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2019-results-and-host 2020-02-19T16:15:32-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-3 2020-02-20T06:00:28-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-record-fourth-quarter-and-full-year-2019 2020-02-25T16:05:23-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/are-dietary-fish-oil-supplements-appropriate-dyslipidemia 2020-03-11T11:17:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/risk-cardiovascular-events-patients-hypertriglyceridemia-0 2020-03-11T11:21:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-has-optimal-chain-length-and-degree 2020-03-11T14:44:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-takes-proactive-steps-support-public-health-priorities 2020-03-15T13:56:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eight-data-presentations-relevant-vascepar-icosapent-ethyl 2020-03-16T08:00:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-levels-vascepar-icosapent-ethyl-reduce 2020-03-30T11:45:16-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-comments-ruling-vascepar-anda-litigation 2020-03-30T18:25:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-vascepar-icosapent-ethyl-related-data 2020-03-31T07:00:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-host-conference-call-april-13-2020-provide-preliminary 2020-04-08T16:05:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/emerging-mechanisms-cardiovascular-protection-omega-3-fatty-acid 2020-04-13T13:07:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-has-optimal-chain-length-and-degree-0 2020-04-13T12:38:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-high-density-lipoprotein-hdl 2020-06-24T14:01:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-inhibits-oxidation-very-large-density 2020-06-24T14:04:46-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cost-effectiveness-icosapent-ethyl-us-reduce-it-patients 2020-06-24T13:59:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-hdl-subclasses-baseline-coronary-plaque-burden 2020-06-24T13:56:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-inflammatory-markers-baseline-coronary-plaque 2020-06-24T13:57:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-eligibility-and-preventable-first-and-total 2020-06-24T13:52:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/residual-cardiovascular-risk-us-veterans-moderately-elevated 2020-06-24T13:50:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2020-results-and-host-conference 2020-04-28T07:01:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2020-financial-results-and-provides 2020-04-30T05:00:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/endothelial-cell-infection-and-endotheliitis-covid-19 2020-05-18T15:38:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/can-bioactive-lipids-inactivate-coronavirus-covid-19 2020-05-18T15:39:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/emerging-mechanisms-cardiovascular-protection-omega-3-fatty-0 2020-05-18T15:39:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-more-effective-docosahexaenoic-acid 2020-05-18T14:21:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/correlation-analysis-omega-3-fatty-acids-and-mortality-sepsis 2020-05-18T14:06:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/antioxidant-and-cardioprotective-effects-epa-early-low-severity 2020-05-18T15:41:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/lipid-mediator-protectin-d1-inhibits-influenza-virus-replication 2020-05-18T14:07:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/influenza-time-target-host 2020-05-18T14:08:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/combination-aspirin-essential-fatty-acids-superior-aspirin-alone 2020-05-18T14:07:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/presenting-characteristics-comorbidities-and-outcomes-among-5700 2020-05-18T15:41:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-preserves-diaphragm-force-generation 2020-05-18T14:09:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/novel-effect-eicosapentaenoic-acid-improved-diaphragm-strength 2020-05-18T14:21:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/covid-backgrounder 2020-10-29T08:46:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-between-triglycerides-and-incident-cardiovascular 2021-01-06T12:42:02-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-shows-significant-reduction-coronary 2020-05-14T14:50:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-improves-endothelial-function-and-nitric-0 2020-05-18T15:44:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/inflammation-resolution-dual-pronged-approach-averting-cytokine 2020-05-18T15:47:33-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-supports-trial-investigate-effects-vascepar-icosapent 2020-05-21T16:05:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/comparison-mineral-oil-and-non-mineral-oil-placebo-coronary-0 2020-05-27T11:29:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-plans-increase-vascepar-icosapent-ethyl-promotion-and 2020-06-01T07:00:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-shows-significant-cardiovascular-risk 2020-06-15T07:00:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-patent-litigation-settlement-agreement-apotex 2020-06-16T16:30:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/response-bhatt-et-al-letter-regarding-article-reduce-it-usa 2020-06-19T15:00:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-us-adults-triglycerides-150-mgdl-nhanes-2007-2014 2020-06-19T15:43:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reducing-cardiovascular-disease-risk-women-beyond-statin-therapy 2020-06-19T16:11:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/substantial-cardiovascular-benefit-icosapent-ethyl-patients 2020-06-19T16:05:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-atheroprotective-properties-and-reduction 2020-08-07T15:36:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/cost-effectiveness-icosapent-ethyl-reduce-it 2020-06-24T13:16:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/elevated-triglycerides-and-atherosclerotic-cardiovascular 2020-06-24T17:12:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reductions-low-density-lipoprotein-cholesterol-and-particle 2020-06-24T13:28:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/elevated-triglycerides-150-mgdl-and-diabetes-mellitus-are 2020-06-24T17:16:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-150-mgdl-associated-greater-risk-cardiovascular 2020-06-24T15:32:14-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/increased-medical-care-costs-patients-statin-controlled-low 2020-06-24T15:36:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-and-atorvastatin-active-metabolite-alone 2020-06-24T15:47:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-reduces-small-dense-low-density 2020-06-24T16:07:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/diabetes-mellitus-and-high-triglycerides-are-significant 2020-06-24T16:29:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-statin-treated-women-persistent-high 2020-06-24T16:54:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-reduces-small-dense-low-density-0 2020-06-24T16:58:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-lipoprotein-particle-concentration-and-0 2020-06-24T17:00:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-not-other-tg-lowering-agents-reversed 2020-06-24T17:02:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-reduces-glucose-induced-small-dense 2020-06-24T17:04:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-amr101-lipid-and-inflammatory-parameters-patients 2020-06-24T17:06:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/long-term-statin-persistence-poor-among-high-risk-patients-1 2020-06-25T12:50:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/beneficial-effects-purified-eicosapentaenoic-acid-myocardial 2020-06-25T12:52:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/high-triglycerides-increase-cardiovascular-events-medical-costs 2020-06-25T13:00:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-statin-0 2020-06-25T15:52:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-0 2020-06-25T16:01:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/high-sensitivity-c-reactive-protein-effects-icosapent-ethyl 2020-06-25T16:50:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/pharmacokinetic-and-triglyceride-lowering-pharmacodynamic 2020-06-25T16:54:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amr101-lowers-triglycerides-atherogenic-lipoprotein 2020-06-25T16:57:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-amr101-pure-ethyl-eicosapentaenoic-acid-omega-3-fatty 2020-06-25T17:02:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-unlike-other-omega-3-fatty-acids-0 2020-06-25T17:08:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-icosapent-ethyl-progression-coronary-atherosclerosis-0 2020-07-07T13:27:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2020-results-and-host-conference 2020-07-21T16:15:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-data-reduce-itr-revasc-including-new 2020-07-27T07:00:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2020-financial-results-and 2020-08-04T06:00:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-plans-maximize-blockbuster-potential-vascepar 2020-08-04T06:30:05-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-supports-investigator-initiated-trial-kaiser-permanente 2020-08-07T12:12:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/applicability-reduce-it-trial-fast-mi-registry-are-results 2020-08-07T15:16:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/response-letter-editor-regarding-critical-differences-between 2020-08-07T15:20:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/association-between-triglycerides-and-residual-cardiovascular-0 2020-08-07T15:23:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/epa-levels-and-cardiovascular-outcomes-reduction-cardiovascular 2020-08-07T15:37:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduction-revascularization-patients-hypertriglyceridemia 2020-08-07T15:46:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-clinical-research-evaluating-vascepar-icosapent-ethyl 2020-08-17T07:00:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-reported-significantly-reduce-coronary 2020-08-29T03:14:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-supports-latest-clinical-research-evaluating-vascepar 2020-09-01T16:31:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-update-following-ruling-vascepar-anda-patent 2020-09-03T10:51:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-lesson-genetics-0 2020-09-09T13:30:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/does-high-dose-fish-oil-reduce-cardiovascular-events-0 2020-09-08T15:35:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/prevalence-hypertriglyceridaemia-statin-treated-very-high-risk-0 2020-09-08T15:36:23-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-therapy-associated-decreased-coronary-0 2020-09-08T15:37:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/triglycerides-150-mgdl-and-above-are-associated-increased-risk 2020-09-08T15:45:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-eicosapentaenoic-acid-ethyl-ester-effects-2 2020-09-08T15:51:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-amr101-lipid-and-inflammatory-parameters-patients-0 2020-09-08T16:00:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amr101-pure-epa-omega-3-fatty-acid-lowers-triglycerides-patients 2020-09-08T16:15:46-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-amr101-pure-epa-omega-3-fatty-acid-fatty-acid-profile 2020-09-08T16:17:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-2020-cantor-virtual-global-healthcare-conference 2020-09-09T11:38:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effect-icosapent-ethyl-progression-coronary-atherosclerosis-1 2020-10-29T08:50:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/covid-19-end-endothelial-disease 2020-09-09T12:50:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-eligibility-and-preventable-cardiovascular-events-us 2020-09-09T12:53:33-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/case-adding-eicosapentaenoic-acid-icosapent-ethyl-abcs 2020-09-09T13:21:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/budoff-mj-final-results-evaporate-trial-presented-august-29-2020 2020-09-09T13:28:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-evaluating-vascepar-icosapent-ethyl-mechanisms 2020-10-05T07:00:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-found-significantly-reduce-ischemic 2020-10-15T16:30:50-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2020-results-and-host-conference 2020-10-19T07:01:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/us-veterans-decreased-renal-function-shown-be-higher-risk 2020-10-23T07:00:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-found-significantly-reduce 2020-10-26T07:01:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-vascepar-icosapent-ethyl-related-scientific-findings-be 2020-10-29T07:01:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2020-financial-results-and-provides 2020-11-05T06:01:16-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-stifel-2020-virtual-healthcare-and-jefferies 2020-11-11T16:31:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-found-significantly-reduce-ischemic-0 2020-11-13T10:00:43-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/multiple-new-vascepar-icosapent-ethyl-related-scientific 2020-11-18T07:01:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-shares-topline-data-partners-pivotal-phase-3-study 2020-11-19T18:30:53-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-piper-sandlers-32nd-annual-healthcare-conference 2020-11-24T06:05:24-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-files-patent-infringement-lawsuit-against-hikma 2020-11-30T19:54:58-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-related-scientific-findings-be 2020-12-07T07:00:47-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-encouraging-efficacy-and-safety-results-pilot 2020-12-12T21:32:24-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-multiple-vascepar-icosapent-ethyl-related 2020-12-14T05:00:35-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/road-approval-perspective-role-icosapent-ethyl-cardiovascular 2020-12-21T12:27:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-39th-annual-jp-morgan-healthcare-conference 2021-01-04T06:06:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-insights-icosapent-ethyl-patients-residual-cardiovascular 2021-01-06T10:22:23-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/mechanisms-action-efficacy-and-safety-icosapent-ethyl-bench 2021-01-06T10:24:47-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/mechanistic-insights-cardiovascular-protection-omega-3-fatty 2021-01-06T10:26:52-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/efficacy-and-safety-icosapent-ethyl-hypertriglyceridaemia-recap 2021-01-06T10:28:53-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/mineral-oil-safety-and-use-placebo-reduce-it-and-other-clinical 2021-01-06T10:30:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/journey-omega-3-fatty-acids-cardiovascular-medicine 2021-01-06T10:32:47-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/beyond-cardiovascular-medicine-potential-future-uses-icosapent 2021-01-06T10:37:40-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/impact-expanded-fda-indication-icosapent-ethyl-enhanced 2021-01-06T10:40:28-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/targeting-hypertriglyceridemia-mitigate-cardiovascular-risk 2021-01-06T10:42:22-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-interim-accumulation-data-across-prespecified-interim 2021-01-06T12:35:56-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/estimated-ascvd-risk-according-statin-use-us-adults-borderline 2021-01-06T12:38:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-2020-results-and-2021-outlook 2021-01-07T06:05:25-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/benefits-icosapent-ethyl-across-range-baseline-renal-function 2021-01-07T15:41:15-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/increased-residual-cardiovascular-risk-us-veterans-moderately 2021-01-07T15:44:42-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/significant-cardiovascular-benefits-icosapent-ethyl-reduce-it 2021-01-07T15:48:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/treatment-icosapent-ethyl-reduce-ischemic-events-patients-prior 2021-01-08T09:36:13-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/omega-3-fatty-acid-treatment-obese-patient-hypertension-and-0 2021-01-08T09:38:40-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-reduces-potentially-atherogenic-lipid-and-2 2021-01-08T09:40:44-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/managing-lipid-triad-improving-physicians-understanding-role-0 2021-01-08T09:45:30-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-included-chinese-society-cardiology-csc-updated 2021-01-21T16:31:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-expands-cardiovascular-risk-reduction-patent-infringement 2021-01-25T19:36:32-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-positive-chmp-opinion-icosapent-ethyl 2021-01-29T12:52:36-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-update-vascepar-icosapent-ethyl-regulatory 2021-02-09T07:00:32-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2020-results-and-host 2021-02-17T08:06:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-4 2021-02-18T06:05:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-full-year-2020-financial 2021-02-25T05:55:46-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-found-prespecified-and-post-hoc 2021-03-17T11:31:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/fifteen-medical-societies-now-recommend-icosapent-ethyl-reduce 2021-03-29T07:01:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-european-commission-ec-approval-vazkepa-reduce 2021-03-30T06:26:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-commences-commercial-initiatives-vazkepa-european-union 2021-04-06T06:06:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-ceo-succession-plan 2021-04-12T16:30:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-reported-impact-vulnerable-coronary 2021-04-17T09:50:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-results-and-host-conference-call 2021-04-20T06:06:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-great-britain-marketing-authorization-vazkepa 2021-04-22T10:53:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-planned-retirement-joseph-t-kennedy-evp-general 2021-04-29T06:01:06-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2021-financial-results-and-provides 2021-04-29T06:10:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/clinical-data-and-other-research-results-regarding-vascepar 2021-05-04T07:00:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-itr-heart-failure-analyses-vascepar-icosapent-ethyl 2021-05-15T08:01:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-multiple-scientific-findings-vascepar 2021-05-17T16:06:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-investor-conferences-june-2021 2021-05-18T06:06:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/further-insights-mechanism-action-icosapent-ethyl-and-its-unique 2021-06-02T16:31:12-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-and-six-month-2021-financial 2021-07-15T06:35:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-and-six-month-2021-financial 2021-08-05T06:00:49-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-clinical-research-evaluating-vasceparvazkepa-icosapent 2021-08-16T07:00:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-data-reduce-itr-showing-vasceparvazkepa-icosapent 2021-08-23T03:15:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-overview-latest-clinical-research-evaluating 2021-08-31T07:00:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-september-investment-conferences 2021-09-13T06:00:41-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-first-european-launch-vazkepa-icosapent-ethyl 2021-09-13T07:00:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-outlines-new-go-market-strategy-accelerate-vascepar 2021-09-22T09:15:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2021-financial-results-and-host 2021-10-20T07:05:17-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2021-financial-results-and-provides 2021-11-03T06:00:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-evaluating-vasceparvazkepa-icosapent-ethyl-be 2021-11-08T07:00:45-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-5 2021-11-11T07:00:54-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-subgroup-data-reduce-itr-highlighting-benefits 2021-11-15T16:30:34-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-overview-latest-clinical-research-evaluating-0 2021-11-16T07:00:54-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-40th-annual-jp-morgan-healthcare-conference 2022-01-04T07:01:53-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-2021-revenue-and-outlook-2022 2022-01-10T07:02:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2021-financial 2022-02-15T08:01:58-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/jama-publication-highlights-vascepar-icosapent-ethyl 2022-02-24T07:32:22-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-participate-cowen-42nd-annual-health-care-conference 2022-02-25T08:00:37-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-full-year-2021-financial 2022-03-01T06:00:50-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-analysis-shows-vascepar-icosapent-ethyl-significantly 2022-03-10T08:48:57-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-evaluating-vascepar-icosapent-ethyl-be-presented 2022-03-21T08:32:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-reimbursement-vazkepar-sweden 2022-03-28T07:01:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/majithia-bhatt-dl-friedman-miller-m-steg-pg-brinton-ea-jacobson 2022-04-15T15:16:03-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/verma-s-bhatt-dl-steg-g-miller-m-brinton-ea-jacobson-ta-dhingra 2022-04-15T15:11:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/peterson-be-bhatt-dl-steg-pg-miller-m-brinton-ea-jacobson-ta 2022-03-30T17:49:30-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/singh-n-bhatt-dl-miller-m-steg-g-brinton-ea-jacobson-ta-jiao-l 2022-04-15T14:52:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/peterson-be-bhatt-dl-steg-pg-miller-m-brinton-ea-jacobson-ta-0 2022-04-15T14:47:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/kosmopoulos-bhatt-dl-meglis-g-verma-r-pan-y-quan-teoh-h-verma-m 2022-04-15T15:38:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/eicosapentaenoic-acid-epa-combined-widely-used-statins 2022-04-01T07:01:33-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/chapman-mj-zamorano-jl-parhofer-kg 2022-04-15T15:21:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/weintraub-ws-bhatt-dl-zhang-z-dolman-s-boden-we-bress-ap-king-jb 2022-04-15T15:22:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/picard-f-bhatt-dl-ducrocq-g-ohman-em-goto-s-eagle-ka-wilson-pwf 2022-04-15T15:26:18-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/boden-we-baum-s-toth-pp-fazio-s-bhatt-dl 2022-04-15T15:29:03-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/olshansky-b-chung-mk-budoff-mj-philip-s-jiao-l-doyle-rt-jr 2022-04-15T15:34:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/peterson-be-bhatt-dl-steg-pg-miller-m-brinton-ea-jacobson-ta-1 2022-04-15T15:05:46-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2022-financial-results-and-host 2022-04-19T07:30:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/nelson-jr-budoff-mj-wani-or-le-v-patel-dk-nelson-nemiroff-rl 2022-04-20T11:17:11-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/mason-rp-eckel-rh-mechanistic-insights-reduce-it-strengthen-case 2022-04-20T11:23:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-partner-hls-therapeutics-completes-reimbursement 2022-04-26T08:49:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-analysis-reveals-icosapent-ethyl-significantly-reduces-risk 2022-05-03T08:02:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2022-financial-results-and-provides 2022-05-04T07:01:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-6 2022-05-12T08:00:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/research-presented-american-heart-associations-quality-care-and 2022-05-16T08:01:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-appointment-new-directors-and-board-leadership 2022-05-19T08:24:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-tom-reilly-new-chief-financial-officer 2022-06-06T08:15:10-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-comprehensive-cost-reduction-plan-address 2022-06-06T08:30:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-positive-recommendation-united-kingdoms-uk 2022-06-10T06:00:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reduce-it-exploratory-post-hoc-biomarker-sub-analysis-shows 2022-06-30T16:05:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/nice-issues-final-guidance-reimbursement-making-vazkepar 2022-07-13T08:01:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2022-financial-results-and-host 2022-07-20T08:00:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2022-financial-results-and 2022-08-03T07:01:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-evaluating-vasceparvazkepa-icosapent-ethyl-and 2022-08-15T08:00:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-itr-data-show-vasceparvazkepar-icosapent-ethyl 2022-08-26T08:19:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-itr-data-show-vasceparvazkepar-icosapent-ethyl-0 2022-08-29T16:14:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-hc-wainwrights-24th-annual-global-investment 2022-08-30T08:00:48-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-board-directors-issues-statement-response-sarissa 2022-10-11T16:16:31-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2022-financial-results-and-host 2022-10-20T08:01:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-adam-berger-and-geraldine-murphy-board-directors 2022-10-20T16:31:13-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2022-financial-results-and-provides 2022-10-27T07:01:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-key-data-presented-american-heart-association 2022-11-07T08:03:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-jefferies-london-healthcare-conference-0 2022-11-09T08:01:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-vazkepar-icosapent-ethyl-approved-therapeutic 2022-11-15T07:01:19-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-vazkepar-icosapent-ethyl-receives-regulatory 2022-12-07T08:31:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-41st-annual-jp-morgan-healthcare-conference 2022-12-14T07:01:24-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-board-directors-announces-appointment-murray-w-stewart-dm 2023-01-10T07:01:20-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-fourth-quarter-and-full-year-2022 2023-01-10T07:15:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-comments-sarissas-notice-call-special-meeting-amarin 2023-01-11T16:34:23-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-responds-inaccurate-and-misleading-statement-sarissa 2023-01-19T07:00:45-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-svb-securities-global-biopharma-conference 2023-01-27T08:00:54-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-vazkepar-icosapent-ethyl-approved-medsafe-new 2023-01-27T08:45:43-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-files-definitive-proxy-materials-and-mails-letter 2023-01-31T08:26:38-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-mails-letter-shareholders-highlighting-sarissas-myths-vs 2023-02-06T08:01:52-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-mails-letter-highlighting-why-shareholders-should-vote 2023-02-09T08:01:31-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-shareholders-invited-webcast-board-and-management-team 2023-02-13T08:01:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/leading-independent-proxy-advisory-firm-glass-lewis-recommends 2023-02-13T19:48:50-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-clearly-and-definitively-instructed-registrar-accept-all 2023-02-16T09:44:52-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/leading-independent-proxy-firm-iss-joins-glass-lewis 2023-02-16T12:35:21-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-urges-shareholders-vote-against-sarissas-harmful 2023-02-17T09:04:30-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2022-financial 2023-02-21T08:03:09-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-cowens-43rd-annual-health-care-conference 2023-02-22T08:02:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-corporation-present-new-data-evaluating-vasceparvazkepar 2023-02-27T08:02:07-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-sets-record-straight-sarissas-latest-misstatements 2023-02-27T16:30:28-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-csl-seqirus-announce-exclusive-license-and 2023-02-28T08:05:38-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-preliminary-voting-results-following-2023 2023-02-28T10:39:45-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-full-year-2022-financial 2023-03-01T07:01:45-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-new-reduce-itr-data-acc23wcc-showing-benefit 2023-03-05T10:22:04-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-new-evidence-therapeutic-value-epa-reducing 2023-03-06T08:00:41-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-board-departures 2023-03-06T16:07:14-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/reconstituted-amarin-board-ready-challenge-unlocking-true 2023-03-16T08:02:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-vazkepar-icosapent-ethyl-approved-israels 2023-04-04T08:01:14-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-names-aaron-berg-interim-president-chief-executive 2023-04-17T07:00:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2023-financial-results-and-host 2023-04-19T08:01:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2023-financial-results-and-provides 2023-05-03T07:01:00-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-new-data-providing-potential-mechanistic 2023-05-12T11:01:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-partner-eddingpharm-receives-regulatory-approval-vascepar 2023-06-01T06:01:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-two-upcoming-investor-conferences-7 2023-06-01T16:31:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-vascepar-icosapent-ethyl-approved-reduce 2023-06-21T09:03:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-implements-organizational-restructuring-strengthen 2023-07-18T16:15:32-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-patrick-holt-president-and-chief-executive 2023-07-18T16:16:45-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-board-directors-announces-executive-compensation-program 2023-07-20T08:01:14-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-positive-recommendation-spanish-drug-pricing 2023-07-25T16:05:27-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-evaluating-clinical-benefits-vasceparvazkepar 2023-07-26T08:01:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-lotus-pharmaceuticals-announce-exclusive-partnership 2023-07-31T08:01:03-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2023-financial-results 2023-08-02T07:11:52-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/scottish-medicines-consortium-accepts-vazkepar-icosapent-ethyl 2023-08-07T07:01:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-neopharm-announce-exclusive-commercialization 2023-08-08T07:01:25-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-pricing-reimbursement-updates-vazkepa-icosapent 2023-08-09T16:06:28-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-2023-cantor-global-healthcare-conference 2023-09-12T08:01:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2023-financial-results-and-host 2023-10-19T08:01:08-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-evaluating-vasceparvazkepar-icosapent-ethyl-and 2023-10-26T08:00:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-jonathan-provoost-executive-vice-president-chief 2023-10-31T12:00:15-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2023-financial-results 2023-11-01T07:01:05-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-itr-analyses-show-vascepar-icosapent-ethyl-associated 2023-11-12T09:00:32-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-42nd-annual-jp-morgan-healthcare-conference 2023-12-11T08:01:01-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-preliminary-fourth-quarter-2023-selected 2024-01-10T07:00:56-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-chairman-ceo-issue-letter-shareholders 2024-01-22T07:30:41-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2023-financial 2024-02-15T08:00:12-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-full-year-2023-financial 2024-02-29T07:00:34-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/research-evaluating-benefits-vasceparvazkepar-icosapent-ethyl-be 2024-03-25T08:00:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-provides-update-vazkepar-icosapent-ethyl-intellectual 2024-04-03T08:00:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-itr-analyses-show-vasceparvazkepar-icosapent-ethyl 2024-04-06T15:30:19-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-key-data-providing-mechanistic-insights 2024-04-08T08:00:34-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2024-financial-results-and-host 2024-04-15T08:00:58-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-results-annual-general-meeting-shareholders 2024-04-22T08:01:01-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-applauds-healthywomens-citizens-petition-urging-fda-take 2024-04-24T14:00:54-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2024-business-update-and-financial 2024-05-01T07:00:43-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-hc-wainwright-2nd-annual-bioconnect-investor 2024-05-06T08:00:35-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-national-reimbursement-vazkepar-icosapent-ethyl 2024-05-28T08:15:59-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-board-directors-announces-ceo-transition 2024-06-04T07:30:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-partner-eddingpharm-receives-regulatory-approval-0 2024-07-08T07:30:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2024-financial-results-and-host 2024-07-17T08:00:44-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-national-reimbursement-vazkepar-icosapent-0 2024-07-17T16:15:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2024-financial-results-and 2024-07-31T07:00:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/latest-research-highlighting-vasceparvazkepar-icosapent-ethyl 2024-08-22T16:39:22-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/research-highlighting-clinical-impact-vasceparvazkepa-icosapent 2024-09-09T07:30:37-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-two-upcoming-investor-events 2024-10-01T08:00:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2024-financial-results-and-provides 2024-10-30T16:05:56-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/investigators-present-new-reduce-it-subanalysis-vasceparvazkepar 2024-11-11T08:00:37-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-peter-fishman-chief-financial-officer 2024-12-13T09:00:39-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-national-reimbursement-vazkepar-italy 2024-12-16T07:00:27-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-national-reimbursement-vazkepar-austria 2025-02-25T08:01:42-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-marks-key-milestone-vasceparvazkepar-icosapent-ethyl 2025-02-27T09:00:52-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-financial-results-business-update 2025-03-12T07:00:57-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-plan-initiate-ratio-change-under-its-american 2025-03-12T07:02:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-research-exploring-mechanistic-benefits-eicosapentaenoic 2025-03-19T07:31:07-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-recent-data-presented-acc25-evaluating 2025-03-31T08:01:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-appoints-jec-capital-partners-michael-torok-board 2025-04-07T07:30:40-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-confirms-effective-date-1-20-ads-ratio-change 2025-04-09T07:30:38-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2025-financial-results-and-host 2025-04-28T16:15:53-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-regains-compliance-nasdaq-minimum-bid-price-requirement 2025-04-29T16:15:21-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-first-quarter-2025-financial-results 2025-05-07T07:00:46-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-exclusive-license-and-supply-agreement 2025-06-24T07:00:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-second-quarter-2025-financial-results-and-host 2025-07-23T07:30:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-second-quarter-2025-financial-results 2025-07-30T07:00:39-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-analyses-reduce-itr-and-epa-mechanistic-data-be-presented 2025-08-25T08:00:24-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-itr-analyses-presented-esc-2025-include-data-showing 2025-08-30T08:30:20-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-key-data-providing-mechanistic-insights-0 2025-09-01T18:19:47-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-hls-therapeutics-collaborate-presenting-reduce-itr 2025-10-14T08:00:42-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-third-quarter-2025-financial-results-and-host 2025-10-15T08:01:02-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-issues-statement-supporting-fdas-action-revise-labeling 2025-10-27T08:01:09-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2025-financial-results 2025-10-29T07:00:51-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-present-new-analyses-affirming-robustness-data-reduce-it 2025-11-03T08:30:39-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-itr-aspirin-analysis-presented-aha-scientific 2025-11-09T16:15:52-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-announces-preliminary-2025-financial-highlights-and 2026-02-06T13:07:24-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-applauds-breakthroughs-therapies-patients-elevated 2026-01-09T07:00:18-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-fourth-quarter-and-full-year-2025-financial 2026-02-11T08:00:48-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/american-heart-month-amarin-spotlights-need-prioritize-proven 2026-02-23T08:01:03-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-fourth-quarter-and-full-year-2025-financial 2026-02-25T07:00:55-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/effects-icosapent-ethyl-risk-and-duration-hospitalizations-and 2026-03-02T08:01:11-05:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/new-reduce-it-data-patients-extreme-cardiovascular-risk-and 2026-03-16T08:15:29-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-highlights-guideline-recommended-role-icosapent-ethyl 2026-03-18T08:30:26-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/american-college-cardiology-acc-scientific-sessions-2026 2026-04-08T08:00:36-04:00 0.5 https://investor.amarincorp.com/news-releases/news-release-details/amarin-report-first-quarter-2026-financial-results-and-host 2026-04-15T08:00:34-04:00 0.5 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0000950117-02-001142 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-02-001146 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000008 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000010 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000013 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000015 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000017 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000019 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000021 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000023 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000025 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000027 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000029 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-02-000031 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0000950137-02-006625 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000002 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000006 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-03-000868 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000008 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000010 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0001159554-03-000012 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0001156973-03-000610 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0000950123-03-004772 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000023 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-03-002441 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000028 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0001156973-03-001153 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-03-003509 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3a/0001156973-03-001212 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001156973-03-001219 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000039 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001156973-03-001407 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-03-000047 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0000950137-03-006114 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-03-005132 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-04-000497 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950117-04-000669 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000002 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-04-008452 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0001104659-04-009105 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-04-014276 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001198877-04-000045 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000019 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001047469-04-024753 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000025 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-04-026615 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-04-027283 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000028 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000029 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-04-029177 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000030 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000031 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-04-000032 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0001104659-04-032379 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-04-001230 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-04-001231 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-04-001232 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-04-001233 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0001159554-04-000039 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-04-035529 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000950129-04-009731 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0001104659-04-039362 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0001047469-04-037648 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0001047469-04-038643 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000003 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000005 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-004308 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-004922 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-007516 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3a/0001047469-05-005120 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000012 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6/0001198877-05-000005 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0001104659-05-014815 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-025060 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0001047469-05-015592 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-025203 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000017 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-025647 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001159554-05-000022 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000023 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000025 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0001159554-05-000029 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001104659-05-034766 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000032 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000034 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000035 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000036 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000038 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-000950 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0001104659-05-048763 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001159554-05-000042 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001072 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001095 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001209 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001229 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001240 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001259 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-05-001278 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000950134-05-024004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000002 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/144/0000950162-06-000024 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-06-000026 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000033 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000950162-06-000079 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000088 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-06-000089 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000100 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0000950162-06-000138 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000147 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000182 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000950162-06-000241 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000260 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000281 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000283 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0000950162-06-000325 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000334 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0001156973-06-000358 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-06-000378 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000399 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000404 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000950162-06-000466 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-06-000467 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000526 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000543 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000545 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000566 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000574 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000594 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000605 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000672 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000731 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000746 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000763 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0000950162-06-000774 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000782 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000801 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000816 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000826 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000836 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-06-001030 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000840 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000851 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001156973-06-000974 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000936 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000946 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-000966 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001002 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0000950162-06-001012 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000950134-06-019194 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001036 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-06-001037 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001093 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001096 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001102 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001130 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001230 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001257 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-06-001267 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000008 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000052 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000062 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000067 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000082 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000950162-07-000091 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000950162-07-000090 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000107 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0001156973-07-000341 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000120 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000130 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000135 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000136 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000142 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000157 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000193 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000206 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-07-000218 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000226 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000950134-07-009780 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000253 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000262 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000297 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000299 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000302 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000306 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000325 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000346 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0000950162-07-000356 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000365 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000368 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-07-000369 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000374 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000385 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000396 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-07-000400 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000444 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000460 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000469 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000473 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000492 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000495 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000560 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000593 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000596 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0000950162-07-000613 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000642 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000685 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000691 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000696 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6ef/0001193805-07-002995 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000703 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000743 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000744 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0000950162-07-000749 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0000950162-07-000751 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000768 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-ka/0000950162-07-000770 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000781 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000910662-07-000575 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-07-000789 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000008 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-08-000009 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000010 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000012 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000014 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000034 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193805-08-000122 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000036 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b2/0000950162-08-000047 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000052 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000056 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000059 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000071 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000120 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000222 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0000950162-08-000232 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000235 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000241 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000929638-08-000326 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-08-028034 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000261 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0000950162-08-000271 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000277 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-08-002117 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000287 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000313 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000371 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000374 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000385 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0000950162-08-000389 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000391 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000392 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000445 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000458 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000461 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-08-000549 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000040 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000006 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000008 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000242 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000009 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000267 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000010 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/nt-20-f/0000950162-09-000287 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000289 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000299 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000929638-09-001169 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001157523-09-004790 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000011 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000929638-09-001256 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000330 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000012 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000013 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000014 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000015 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000016 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000017 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000018 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000019 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0000950162-09-000453 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000950123-09-053207 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000905718-09-000542 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001140361-09-023850 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000930413-09-005359 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001140361-09-023853 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000929638-09-001495 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/d/0000950162-09-000469 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000475 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000488 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000897448-09-000021 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-fa/0000950162-09-000491 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-09-027209 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000504 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-1/0000950162-09-000505 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-09-000510 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0000950162-09-000511 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950123-10-000384 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-10-000004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-1a/0000950162-10-000017 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-10-000345 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001104659-10-003713 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0000950162-10-000039 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000947871-10-000133 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000947871-10-000134 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-000149 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-000150 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-000559 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-000560 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-130362 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-138951 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/20-f/0001193125-10-146179 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-146186 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950123-10-062330 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-155805 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-10-156660 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-10-156662 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-186204 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-186201 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-190830 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-190831 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950123-10-081327 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-000936 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-000937 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-213968 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-213970 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-10-052404 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-233672 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-234213 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-10-055388 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-10-057844 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-255273 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-255276 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-255288 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-255301 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-3/0001193125-10-255411 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pos-am/0001193125-10-255417 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-10-003342 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-10-003357 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-269734 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-269740 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0001140361-10-048396 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-277519 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-001108 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-10-001109 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-10-065706 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000315066-10-003929 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-10-066666 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-283867 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/0001193125-10-283871 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-285550 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-10-287763 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-10-000214 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064135 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064249 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064250 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064253 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064256 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064257 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064258 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064259 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064260 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-10-064262 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000947871-11-000012 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-001353 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-11-002055 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001140361-11-001414 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/fwp/0001193125-11-002577 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6ef/0001193805-11-000029 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-11-002937 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-002959 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-002836 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-ka/0001193125-11-005357 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-11-010723 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-11-000004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-019014 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-006541 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-006542 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-11-000793 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3a/0001181431-11-009311 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-009328 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0001140361-11-008561 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0001140361-11-008587 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000930413-11-001056 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000315066-11-002220 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-012892 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-012895 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-013667 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-014039 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-013380 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000143 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000144 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-014276 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-11-000190 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-11-000191 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000203 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000204 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-015160 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-016879 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-015754 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-017543 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-017938 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-016696 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000283 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000284 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-11-000090 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-11-068866 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-069027 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000334 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000335 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-11-006045 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-020426 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000349 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000350 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pos-am/0001193125-11-079996 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pos-am/0001193125-11-079994 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pos-am/0001193125-11-079998 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3asr/0001193125-11-080006 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pos-am/0001193125-11-080000 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-11-000807 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-11-000805 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-11-000806 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-11-000810 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-020948 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-022850 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-100389 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-022726 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-024821 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-024822 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-024823 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-024827 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000410 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000411 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-11-103993 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000421 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000422 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0000947871-11-000426 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0000947871-11-000427 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0001181431-11-025665 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-025669 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-11-000440 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000947871-11-000439 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-11-122130 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-122141 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000462 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-11-000463 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-11-000101 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001140361-11-026072 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-133204 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-11-134080 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-030238 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-030241 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-11-149148 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-156164 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-11-156415 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-156413 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-041139 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-041141 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-041255 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-041256 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-188809 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-041369 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0001181431-11-041374 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-041451 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-041452 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-216687 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-11-216699 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-217355 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-046489 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950123-11-079751 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-11-250369 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6/0001193125-11-250379 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-256063 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-261339 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-053003 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-053004 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-11-000167 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-276180 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-053325 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-297373 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-11-003172 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-055113 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-300224 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-11-300743 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000902664-11-001615 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-11-016789 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-321689 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-327499 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000315066-11-004650 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-340315 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-060651 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-060656 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-11-061421 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-061422 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-11-058751 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-11-061837 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-11-351925 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-000041 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-002176 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-007211 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-002429 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-004748 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-12-005242 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005923 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005925 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005928 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005930 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005933 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005935 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-005938 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000902664-12-000301 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000315066-12-002355 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-064391 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-12-010598 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-12-089181 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-089271 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-093132 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-014295 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-12-119766 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-12-003556 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-123535 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-019802 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-020746 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-022463 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001140361-12-019608 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-023000 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-12-155203 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-023738 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-023903 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-12-000123 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001144204-12-022786 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/0001193125-12-185899 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0001140361-12-021579 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-12-000131 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-12-191568 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-218353 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-12-218377 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-033788 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-12-000169 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-035613 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-037304 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-12-000493 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-12-000494 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-038207 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-296285 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-300939 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040563 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040565 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040566 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040571 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040573 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040575 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-040666 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-307246 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-317944 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-12-000205 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-042741 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-042742 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-042743 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-042745 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-042747 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-12-000570 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-12-000571 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-12-012388 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-344034 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-12-344051 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-12-344198 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-045875 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-359991 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-12-000627 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000947871-12-000628 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-048819 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-386753 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-049925 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-12-013551 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-051885 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-053566 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-419267 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-054551 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-460352 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-12-460371 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-12-014799 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-484721 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000315066-98-000062 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000315066-98-001867 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000899243-00-001695 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000950162-01-000111 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000899243-01-501498 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000899243-01-502001 2012-12-08T10:40:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-12-064101 2012-12-12T16:56:23-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-12-064103 2012-12-12T16:58:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-500248 2012-12-12T17:08:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-12-508520 2012-12-19T17:12:38-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-000555 2013-01-02T20:03:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-000556 2013-01-02T20:05:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-000557 2013-01-02T20:05:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-000558 2013-01-02T20:07:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-003023 2013-01-14T07:12:39-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-024227 2013-01-25T17:06:40-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-005598 2013-01-30T18:00:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000902664-13-000726 2013-02-13T14:05:10-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000315066-13-002213 2013-02-14T13:41:45-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000899140-13-000163 2013-02-14T15:44:35-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-078310 2013-02-27T07:12:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-084157 2013-02-28T16:15:09-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-13-084191 2013-02-28T16:19:18-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0001193125-13-124295 2013-03-25T16:28:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/9999999997-02-006523 2013-03-27T21:07:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/9999999997-02-010245 2013-03-27T21:07:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/9999999997-02-012671 2013-03-27T21:07:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/6-k/9999999997-02-021917 2013-03-27T21:07:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b3/9999999997-02-024354 2013-03-27T21:07:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-132344 2013-03-28T16:26:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-022144 2013-04-15T08:46:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-13-008247 2013-04-17T13:05:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-159813 2013-04-18T06:31:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-165927 2013-04-23T06:42:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-13-165410 2013-04-23T06:44:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-023453 2013-04-25T16:25:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-184225 2013-04-30T06:43:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/9999999997-13-009091 2013-05-01T10:52:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-210988 2013-05-09T16:11:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-13-211006 2013-05-09T16:13:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-031271 2013-05-29T16:35:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-263459 2013-06-19T08:07:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-036272 2013-06-21T16:08:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-036580 2013-06-25T16:09:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-284852 2013-07-08T16:43:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-13-284873 2013-07-08T16:55:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-13-287368 2013-07-10T17:23:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-287377 2013-07-10T17:27:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-039459 2013-07-11T06:59:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-039458 2013-07-11T06:59:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-039457 2013-07-11T06:59:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-039460 2013-07-11T07:01:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-039461 2013-07-11T07:09:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-039586 2013-07-11T17:05:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-289412 2013-07-12T16:13:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000905718-13-000180 2013-07-22T10:13:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-041549 2013-07-26T17:00:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-041551 2013-07-26T17:02:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-041552 2013-07-26T17:02:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-326797 2013-08-08T16:09:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-13-326829 2013-08-08T16:15:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001144204-13-047632 2013-08-23T14:32:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-401180 2013-10-16T17:19:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-406664 2013-10-22T16:27:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-416032 2013-10-29T16:34:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-432797 2013-11-07T16:12:21-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-13-432814 2013-11-07T16:18:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-059457 2013-11-18T16:18:47-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-059913 2013-11-20T16:23:28-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-13-059993 2013-11-20T18:14:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-450343 2013-11-22T06:05:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-459177 2013-12-02T16:09:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-474012 2013-12-16T09:09:09-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-13-479902 2013-12-20T06:59:28-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001181431-14-001984 2014-01-09T16:19:33-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-002131 2014-01-10T16:46:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-002130 2014-01-10T16:46:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-002129 2014-01-10T16:46:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-002128 2014-01-10T16:46:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-008154 2014-01-10T17:28:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-020544 2014-01-24T17:20:28-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-062747 2014-02-21T16:13:46-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-072943 2014-02-27T16:10:32-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-14-072975 2014-02-27T16:12:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-081276 2014-03-04T06:16:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-086742 2014-03-06T17:03:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012611 2014-03-13T16:33:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012610 2014-03-13T16:33:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012608 2014-03-13T16:33:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012609 2014-03-13T16:33:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012607 2014-03-13T16:33:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012612 2014-03-13T16:35:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-012613 2014-03-13T16:35:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-100184 2014-03-14T16:48:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-124011 2014-03-31T16:43:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-14-168276 2014-04-30T06:09:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-190998 2014-05-09T07:09:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-14-191000 2014-05-09T07:11:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-199919 2014-05-15T06:17:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/9999999997-14-009891 2014-05-16T11:14:40-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-208337 2014-05-21T17:05:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-14-011494 2014-06-26T16:27:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-265482 2014-07-10T16:33:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3/0001193125-14-300722 2014-08-07T16:21:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-300738 2014-08-07T16:23:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-14-300747 2014-08-07T16:25:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/del-am/0001193125-14-311785 2014-08-15T16:24:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-14-002588 2014-08-25T06:05:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-342253 2014-09-16T06:13:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-373248 2014-10-16T08:06:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-400956 2014-11-06T16:06:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-14-400975 2014-11-06T16:11:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-036264 2014-11-12T20:03:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-14-036263 2014-11-12T20:03:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-14-413357 2014-11-14T16:48:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000935836-14-000625 2014-11-19T15:00:39-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-007290 2015-01-12T08:05:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-15-001782 2015-02-02T21:52:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-15-001785 2015-02-02T21:54:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-15-001783 2015-02-02T21:54:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001181431-15-001784 2015-02-02T21:54:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-030303 2015-02-03T06:19:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000935836-15-000101 2015-02-09T13:38:31-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-075052 2015-03-03T16:08:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-15-075070 2015-03-03T16:19:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-086411 2015-03-11T08:04:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-111848 2015-03-30T16:36:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0001193125-15-119012 2015-04-03T16:22:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3/0001193125-15-124231 2015-04-09T16:14:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6/0001193805-15-000607 2015-04-22T17:22:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-15-146859 2015-04-24T17:05:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3a/0001193125-15-146883 2015-04-24T18:49:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-150702 2015-04-28T06:34:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-15-001160 2015-05-04T06:06:41-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-15-001178 2015-05-04T06:08:48-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-177093 2015-05-07T16:15:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-178192 2015-05-08T06:23:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-15-178199 2015-05-08T06:31:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/9999999997-15-009686 2015-05-14T14:51:53-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-206783 2015-05-29T16:47:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-15-011412 2015-07-01T14:08:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060171 2015-07-08T18:37:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060172 2015-07-08T18:37:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060174 2015-07-08T18:41:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060176 2015-07-08T18:43:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060179 2015-07-08T18:51:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060180 2015-07-08T18:53:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060187 2015-07-08T19:02:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060184 2015-07-08T19:02:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060189 2015-07-08T19:07:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060199 2015-07-08T19:58:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060202 2015-07-08T20:02:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-250353 2015-07-10T16:22:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-060798 2015-07-14T16:39:03-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3/0001193125-15-262778 2015-07-24T16:38:53-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-15-262782 2015-07-24T16:39:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-280963 2015-08-06T16:06:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-15-280984 2015-08-06T16:23:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-283165 2015-08-07T16:45:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-15-002220 2015-08-10T06:09:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-065240 2015-08-11T16:36:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-073266 2015-10-02T16:37:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-073268 2015-10-02T16:41:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-15-074354 2015-10-06T16:35:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-365180 2015-11-04T07:05:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-15-365184 2015-11-04T07:09:01-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-382757 2015-11-20T06:11:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-15-391271 2015-12-01T06:14:20-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-087894 2016-01-04T17:20:33-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-087891 2016-01-04T17:21:39-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-425700 2016-01-11T07:05:44-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-436266 2016-01-25T07:51:35-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-094724 2016-02-02T16:24:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-094731 2016-02-02T16:25:40-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-094735 2016-02-02T16:33:12-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-094719 2016-02-02T16:37:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-095108 2016-02-03T08:17:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000935836-16-000728 2016-02-12T13:22:31-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-476858 2016-02-25T07:05:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-16-476872 2016-02-25T07:11:04-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-498380 2016-03-09T16:06:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-111790 2016-04-01T18:01:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-111793 2016-04-01T18:04:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-16-569293 2016-04-29T16:28:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-578634 2016-05-05T07:03:58-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-16-578644 2016-05-05T07:10:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-609131 2016-06-01T06:15:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-615888 2016-06-08T06:33:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-638222 2016-06-30T16:10:09-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001209191-16-131304 2016-07-05T19:09:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-131307 2016-07-05T19:12:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-131311 2016-07-05T19:14:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-131309 2016-07-05T19:14:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132566 2016-07-13T16:27:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132567 2016-07-13T16:27:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132569 2016-07-13T16:29:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132573 2016-07-13T16:32:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132571 2016-07-13T16:32:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132576 2016-07-13T16:33:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-132575 2016-07-13T16:33:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-648264 2016-07-14T16:12:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-670843 2016-08-04T06:16:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-16-670851 2016-08-04T06:18:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-16-678222 2016-08-10T17:24:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-16-680725 2016-08-12T16:12:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-680739 2016-08-12T16:16:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6ef/0001193805-16-003723 2016-08-12T16:45:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-681349 2016-08-15T07:40:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-693960 2016-08-26T16:39:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-709674 2016-09-14T16:17:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-718503 2016-09-23T16:49:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-143446 2016-09-30T21:28:09-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-143447 2016-09-30T21:30:09-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-757903 2016-11-03T06:14:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-16-757909 2016-11-03T06:16:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-16-149390 2016-11-10T17:05:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-16-795805 2016-12-16T16:12:32-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-i/0001193125-16-795848 2016-12-16T16:35:33-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-000248 2017-01-03T17:07:48-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-000245 2017-01-03T17:08:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-003040 2017-01-05T16:48:54-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-013610 2017-01-20T07:21:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-ia/0001193125-17-013611 2017-01-20T07:21:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-017999 2017-01-25T16:08:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-007156 2017-02-02T17:07:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-007161 2017-02-02T17:08:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-007170 2017-02-02T17:10:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-007167 2017-02-02T17:10:12-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-060177 2017-02-28T06:36:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-17-065969 2017-03-01T17:15:18-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3asr/0001193125-17-066014 2017-03-01T17:23:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3asr/0001193125-17-066018 2017-03-01T17:27:21-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-097592 2017-03-27T16:22:40-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-024219 2017-04-03T17:04:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-024221 2017-04-03T17:07:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-17-131308 2017-04-21T06:49:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-154965 2017-05-03T07:05:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-17-008215 2017-05-03T07:10:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-033237 2017-05-17T17:16:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-033269 2017-05-17T17:27:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-033265 2017-05-17T17:27:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-033273 2017-05-17T17:30:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-033272 2017-05-17T17:30:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-033271 2017-05-17T17:30:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-175994 2017-05-19T09:09:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-042900 2017-07-03T19:22:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-042901 2017-07-03T19:24:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-042903 2017-07-03T19:24:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-042902 2017-07-03T19:24:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-17-014759 2017-08-02T06:34:46-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-17-014760 2017-08-02T06:40:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-17-245945 2017-08-02T17:10:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-17-273154 2017-08-30T16:04:52-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-17-008807 2017-09-22T13:11:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-055092 2017-10-03T16:27:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-055099 2017-10-03T16:30:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-056347 2017-10-06T19:24:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-17-020624 2017-11-01T06:34:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-17-020625 2017-11-01T06:38:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-17-063361 2017-12-04T09:07:52-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0001209191-17-063586 2017-12-04T16:50:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-17-029374 2017-12-21T16:07:33-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3a/0000899243-17-029466 2017-12-22T16:15:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-000217 2018-01-02T16:35:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-000215 2018-01-02T16:36:28-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-003014 2018-01-04T17:01:38-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-002255 2018-01-04T19:43:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-003008 2018-01-09T18:02:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-003659 2018-01-16T18:02:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-004062 2018-01-17T18:03:31-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-004978 2018-01-23T18:04:53-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-18-023588 2018-01-29T16:11:28-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-18-027655 2018-01-31T17:30:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-029435 2018-02-01T17:06:23-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-007271 2018-02-02T20:27:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-007272 2018-02-02T20:27:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-007273 2018-02-02T20:29:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-007274 2018-02-02T20:31:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-007275 2018-02-02T20:34:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-18-003381 2018-02-27T06:33:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001564590-18-003389 2018-02-27T07:22:01-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-023352 2018-04-03T20:14:53-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-023351 2018-04-03T20:14:53-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-107513 2018-04-04T16:20:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-18-004238 2018-04-05T16:25:26-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-18-123721 2018-04-20T08:06:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-125903 2018-04-23T08:03:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-18-010123 2018-05-02T06:33:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-18-010125 2018-05-02T06:37:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-168093 2018-05-18T17:06:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-173647 2018-05-24T16:45:03-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-189948 2018-06-12T06:11:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-040971 2018-07-03T16:17:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-040955 2018-07-03T16:17:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-18-018241 2018-08-01T06:35:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-18-018242 2018-08-01T06:42:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-280561 2018-09-24T07:59:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052201 2018-09-25T18:38:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052203 2018-09-25T18:40:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052202 2018-09-25T18:40:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052384 2018-09-26T20:51:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052386 2018-09-26T20:55:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052388 2018-09-26T20:57:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-052390 2018-09-26T20:59:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053462 2018-10-02T19:05:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053459 2018-10-02T19:05:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053469 2018-10-02T19:07:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053474 2018-10-02T19:11:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053472 2018-10-02T19:11:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053480 2018-10-02T19:15:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053477 2018-10-02T19:15:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053482 2018-10-02T19:17:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-053484 2018-10-02T19:19:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0001144204-18-053267 2018-10-10T17:13:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-303085 2018-10-19T16:35:45-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-18-025978 2018-11-01T07:08:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-18-025979 2018-11-01T07:08:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-056999 2018-11-02T18:14:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-057000 2018-11-02T18:14:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-320898 2018-11-07T16:17:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-324645 2018-11-13T06:20:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-058601 2018-11-14T18:06:00-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-18-334064 2018-11-26T17:34:53-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-18-336730 2018-11-28T17:25:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6ef/0001193805-18-001374 2018-11-29T15:09:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-18-338026 2018-11-29T16:09:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-060457 2018-11-30T18:36:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-18-060458 2018-11-30T18:38:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-000513 2019-01-02T19:48:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-000519 2019-01-02T19:54:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-000521 2019-01-02T19:56:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-000522 2019-01-02T19:58:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-002580 2019-01-04T16:47:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-003496 2019-01-11T20:19:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-003500 2019-01-11T20:21:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-003498 2019-01-11T20:21:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-003499 2019-01-11T20:21:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-003497 2019-01-11T20:21:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-005253 2019-01-24T20:23:41-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-006638 2019-02-01T20:37:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-006637 2019-02-01T20:37:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-006639 2019-02-01T20:39:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-006640 2019-02-01T20:39:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-032293 2019-02-08T16:37:33-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0001144204-19-007232 2019-02-13T16:38:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-010799 2019-02-15T20:21:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-012805 2019-02-22T21:35:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-012807 2019-02-22T21:37:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-012806 2019-02-22T21:37:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-012808 2019-02-22T21:39:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-19-004652 2019-02-27T06:34:12-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001564590-19-004655 2019-02-27T06:42:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-015275 2019-03-01T20:20:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-015273 2019-03-01T20:20:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-015276 2019-03-01T20:22:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-017567 2019-03-06T20:19:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-017568 2019-03-06T20:21:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001209191-19-020688 2019-03-20T20:21:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-094698 2019-04-01T17:12:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-022105 2019-04-01T20:24:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-022107 2019-04-01T20:26:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-022109 2019-04-01T20:28:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0001193125-19-106686 2019-04-15T17:09:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-19-117917 2019-04-25T07:03:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-19-014555 2019-05-01T06:52:58-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-19-014554 2019-05-01T06:52:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-027127 2019-05-02T20:06:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-027157 2019-05-02T21:05:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-027161 2019-05-02T21:09:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-031858 2019-05-21T20:04:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-031860 2019-05-21T20:08:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-031864 2019-05-21T20:12:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-031862 2019-05-21T20:12:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-031866 2019-05-21T20:14:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-031868 2019-05-21T20:16:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-155481 2019-05-23T17:06:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-159578 2019-05-29T16:12:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-033765 2019-05-31T20:06:48-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-033767 2019-05-31T20:08:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-038330 2019-06-20T20:08:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-039191 2019-06-26T20:12:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-187778 2019-07-02T08:17:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-040574 2019-07-02T20:08:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-040575 2019-07-02T20:10:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-041299 2019-07-03T20:03:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-041298 2019-07-03T20:03:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-041297 2019-07-03T20:03:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-041364 2019-07-05T21:02:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-042001 2019-07-12T20:06:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-19-195620 2019-07-17T16:06:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-195687 2019-07-17T16:49:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/424b5/0001193125-19-198150 2019-07-19T17:06:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-201274 2019-07-24T16:37:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-19-027186 2019-07-31T06:44:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-19-027188 2019-07-31T06:44:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-217425 2019-08-09T07:24:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-047192 2019-08-22T20:04:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4a/0001209191-19-047385 2019-08-23T20:22:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-048659 2019-09-05T20:09:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-243359 2019-09-12T06:22:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-052863 2019-10-09T20:03:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-052864 2019-10-09T20:06:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-052865 2019-10-09T20:06:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-052866 2019-10-09T20:07:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-054568 2019-10-30T20:12:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-19-040044 2019-11-05T06:38:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-19-040047 2019-11-05T06:43:20-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-ka/0001564590-19-040492 2019-11-05T17:34:23-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-055751 2019-11-07T20:09:38-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-056488 2019-11-14T04:23:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-056486 2019-11-14T04:28:12-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-292793 2019-11-15T06:38:17-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-057691 2019-11-21T20:52:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-19-314332 2019-12-16T06:46:04-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-061211 2019-12-18T20:07:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-061212 2019-12-18T20:07:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-19-061213 2019-12-18T20:08:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-20-001469 2020-01-03T21:33:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-003036 2020-01-07T16:25:09-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-000883 2020-02-04T20:04:52-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-000881 2020-02-04T20:06:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-000879 2020-02-04T20:06:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-000880 2020-02-04T20:07:12-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-000882 2020-02-04T20:08:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0001104659-20-021750 2020-02-14T16:34:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-20-006386 2020-02-25T16:12:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001564590-20-006390 2020-02-25T16:18:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3asr/0001193125-20-050259 2020-02-26T17:32:19-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-001801 2020-02-27T20:07:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-001800 2020-02-27T20:08:00-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-001797 2020-02-27T20:08:33-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-001798 2020-02-27T20:08:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-001799 2020-02-27T20:09:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002058 2020-03-03T20:05:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002059 2020-03-03T20:05:52-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002061 2020-03-03T20:08:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002062 2020-03-03T20:08:07-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002060 2020-03-03T20:09:17-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002275 2020-03-06T20:08:21-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-092017 2020-03-31T09:26:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002868 2020-04-02T20:16:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002869 2020-04-02T20:16:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002871 2020-04-02T20:17:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002867 2020-04-02T20:17:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-002870 2020-04-02T20:19:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-105284 2020-04-13T16:40:52-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-ka/0001564590-20-019708 2020-04-29T16:13:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-20-019933 2020-04-30T06:34:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-20-019937 2020-04-30T06:39:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-003249 2020-05-01T20:10:03-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-003250 2020-05-01T20:11:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-003252 2020-05-01T20:14:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-003251 2020-05-01T20:14:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-003253 2020-05-01T20:15:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-137711 2020-05-08T17:20:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-20-157264 2020-06-01T16:18:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004105 2020-06-02T20:12:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004106 2020-06-02T20:12:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004104 2020-06-02T20:12:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004103 2020-06-02T20:12:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004107 2020-06-02T20:12:48-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-170550 2020-06-16T17:33:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004940 2020-07-02T20:42:58-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004941 2020-07-02T20:43:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004938 2020-07-02T20:43:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004937 2020-07-02T20:43:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-004939 2020-07-02T20:43:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-192691 2020-07-14T17:21:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005123 2020-07-15T20:07:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005122 2020-07-15T20:07:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005124 2020-07-15T20:08:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005125 2020-07-15T20:08:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005126 2020-07-15T20:12:09-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005127 2020-07-15T20:13:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005255 2020-07-31T20:06:26-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005256 2020-07-31T20:06:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005257 2020-07-31T20:09:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005258 2020-07-31T20:09:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005259 2020-07-31T20:12:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-20-035729 2020-08-04T06:14:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-20-035730 2020-08-04T06:20:31-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-20-208753 2020-08-04T07:42:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005777 2020-09-02T20:04:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005778 2020-09-02T20:05:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005779 2020-09-02T20:09:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005780 2020-09-02T20:10:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-005781 2020-09-02T20:10:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-20-239062 2020-09-03T16:24:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006248 2020-10-02T20:06:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006251 2020-10-02T20:08:03-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006252 2020-10-02T20:08:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006249 2020-10-02T20:08:09-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006250 2020-10-02T20:10:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006417 2020-10-22T20:06:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006527 2020-11-03T20:27:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006528 2020-11-03T20:27:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006529 2020-11-03T20:29:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006530 2020-11-03T20:29:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006531 2020-11-03T20:33:19-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-20-050798 2020-11-05T06:20:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-20-050793 2020-11-05T06:21:10-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-006684 2020-11-12T20:05:07-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-007027 2020-12-02T20:05:08-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-007029 2020-12-02T20:05:44-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-007028 2020-12-02T20:05:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001209191-20-061329 2020-12-02T20:09:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-007031 2020-12-02T20:09:14-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-20-007030 2020-12-02T20:09:17-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000126 2021-01-05T20:04:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000125 2021-01-05T20:05:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000128 2021-01-05T20:06:38-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000127 2021-01-05T20:06:47-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000129 2021-01-05T20:08:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-21-003641 2021-01-07T06:19:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-21-022781 2021-01-29T17:05:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000645 2021-01-29T20:05:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000646 2021-01-29T20:05:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000648 2021-01-29T20:06:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000647 2021-01-29T20:06:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000649 2021-01-29T20:08:40-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-000880 2021-02-03T20:06:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-21-008376 2021-02-25T06:09:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001564590-21-008382 2021-02-25T06:12:23-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-001705 2021-03-01T20:04:17-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-001706 2021-03-01T20:06:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-001707 2021-03-01T20:08:18-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-001708 2021-03-01T20:08:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-001709 2021-03-01T20:09:09-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-002578 2021-04-02T20:06:46-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-002579 2021-04-02T20:08:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-002580 2021-04-02T20:09:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-002581 2021-04-02T20:10:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-002582 2021-04-02T20:10:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-21-113365 2021-04-12T17:28:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001564590-21-021567 2021-04-29T06:32:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001564590-21-021572 2021-04-29T06:41:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-21-140753 2021-04-29T17:04:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003069 2021-04-30T20:05:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003070 2021-04-30T20:07:40-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003071 2021-04-30T20:09:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003072 2021-04-30T20:12:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003073 2021-04-30T20:14:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003848 2021-05-28T20:04:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003849 2021-05-28T20:06:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003850 2021-05-28T20:09:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003852 2021-05-28T20:09:50-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-003851 2021-05-28T20:09:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-21-022406 2021-06-07T21:57:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-21-190656 2021-06-15T08:43:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004328 2021-06-16T20:12:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004325 2021-06-16T20:12:27-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004329 2021-06-16T20:12:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004326 2021-06-16T20:12:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004327 2021-06-16T20:12:38-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004331 2021-06-16T20:12:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004737 2021-07-02T20:12:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004738 2021-07-02T20:12:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004739 2021-07-02T20:12:44-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004740 2021-07-02T20:23:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-004741 2021-07-02T20:23:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005144 2021-08-03T20:12:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005143 2021-08-03T20:12:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005145 2021-08-03T20:13:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005146 2021-08-03T20:22:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005147 2021-08-03T20:22:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005185 2021-08-04T20:13:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005184 2021-08-04T20:13:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005186 2021-08-04T20:22:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-21-000845 2021-08-05T06:21:40-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-21-000843 2021-08-05T06:23:04-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001209191-21-050720 2021-08-10T20:12:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005317 2021-08-13T20:12:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001209191-21-053336 2021-08-25T17:07:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005782 2021-09-02T20:11:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005781 2021-09-02T20:11:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005783 2021-09-02T20:12:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-005784 2021-09-02T20:12:50-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-21-283042 2021-09-27T08:32:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-05-048131 2021-10-02T09:06:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001159554-05-000011 2021-10-02T12:01:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-17-001676 2021-10-02T12:27:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-05-003793 2021-10-02T12:58:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-05-056594 2021-10-02T13:20:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-17-005828 2021-10-02T13:49:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0000950162-05-000918 2021-10-02T14:01:50-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0000950162-10-000018 2021-10-02T14:35:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-15-039798 2021-10-02T15:07:03-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-13-052297 2021-10-02T15:32:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-15-146872 2021-10-02T16:10:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-12-059439 2021-10-02T17:29:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-15-278855 2021-10-02T17:53:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-12-051675 2021-10-02T18:07:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-13-059990 2021-10-03T00:45:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-13-390895 2021-10-03T02:05:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-15-156469 2021-10-03T02:11:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-16-106565 2021-10-03T02:23:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-09-072202 2021-10-03T02:31:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-15-021550 2021-10-03T03:03:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-12-413247 2021-10-03T03:53:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0000950162-10-000019 2021-10-03T03:55:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-21-002719 2021-11-03T06:13:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-21-002721 2021-11-03T06:13:41-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-21-007737 2021-12-16T20:03:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000166 2022-01-04T21:08:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000172 2022-01-04T21:21:07-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000171 2022-01-04T21:21:07-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000169 2022-01-04T21:21:54-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-22-000201 2022-01-10T09:08:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-22-000466 2022-01-13T20:04:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000467 2022-01-13T20:15:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13d/0000899140-22-000088 2022-01-24T17:02:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000982 2022-02-02T20:04:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000984 2022-02-02T20:15:01-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-000983 2022-02-02T20:15:02-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-001244 2022-02-08T20:05:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-001248 2022-02-08T20:14:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-001246 2022-02-08T20:15:01-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-001247 2022-02-08T20:15:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-001245 2022-02-08T20:15:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0001104659-22-022808 2022-02-14T16:24:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-22-002396 2022-03-01T06:30:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0000950170-22-002401 2022-03-01T06:30:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-002152 2022-03-02T20:04:20-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-002155 2022-03-02T20:15:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-002153 2022-03-02T20:16:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-003408 2022-04-14T20:11:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-ka/0001193125-22-136709 2022-05-02T16:05:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-003728 2022-05-03T20:12:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-22-007188 2022-05-04T07:08:40-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-22-007190 2022-05-04T07:12:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-155589 2022-05-20T07:50:41-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-004316 2022-05-20T20:32:46-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-004317 2022-05-20T20:33:48-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-22-004315 2022-05-23T11:26:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-22-004314 2022-05-23T11:26:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-22-158650 2022-05-24T17:18:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000899140-22-000552 2022-06-03T09:19:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-168396 2022-06-06T16:37:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005127 2022-06-15T20:13:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000899140-22-000563 2022-06-16T06:08:58-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-22-176598 2022-06-17T16:53:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005406 2022-06-29T20:12:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005402 2022-06-29T20:12:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005407 2022-06-29T20:12:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005401 2022-06-29T20:12:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005405 2022-06-29T20:12:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005403 2022-06-29T20:12:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005404 2022-06-29T20:12:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-186302 2022-06-30T17:22:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-22-005609 2022-07-06T20:12:53-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005611 2022-07-06T20:23:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005610 2022-07-06T20:23:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005837 2022-08-02T20:12:48-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005838 2022-08-02T20:12:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-005836 2022-08-02T20:12:52-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-22-014007 2022-08-03T07:11:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-22-014008 2022-08-03T07:15:34-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-22-213732 2022-08-05T17:19:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-225367 2022-08-19T16:34:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-006294 2022-08-23T20:12:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001193125-22-260662 2022-10-11T16:33:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001193125-22-260664 2022-10-11T16:36:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-22-260741 2022-10-11T17:26:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-266816 2022-10-21T17:09:10-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-22-020244 2022-10-27T07:09:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-22-020246 2022-10-27T07:12:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-22-007435 2022-11-02T18:32:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-22-007436 2022-11-02T18:32:43-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-007438 2022-11-02T18:35:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-22-007437 2022-11-02T18:35:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-286778 2022-11-16T16:20:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-22-299771 2022-12-07T07:05:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0001104659-22-126318 2022-12-12T16:51:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-000223 2023-01-03T07:04:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-23-000188 2023-01-04T20:36:08-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-23-000190 2023-01-04T20:47:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-23-000189 2023-01-04T20:47:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-ka/0001193125-23-002508 2023-01-05T17:09:48-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-005176 2023-01-10T07:21:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001193125-23-005648 2023-01-10T16:45:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-005718 2023-01-10T17:28:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0000899140-23-000032 2023-01-11T06:04:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-006568 2023-01-11T17:23:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-006958 2023-01-12T09:32:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001562180-23-000403 2023-01-13T06:31:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001562180-23-000402 2023-01-13T06:31:17-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prec14a/0001193125-23-008947 2023-01-17T08:10:31-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-002025 2023-01-18T17:25:38-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prec14a/0001140361-23-002004 2023-01-19T08:45:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-002125 2023-01-19T16:02:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-010954 2023-01-19T16:07:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-013258 2023-01-23T17:27:19-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prer14a/0001193125-23-016842 2023-01-27T08:03:48-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prer14a/0001193125-23-017537 2023-01-27T16:10:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prrn14a/0001140361-23-003132 2023-01-27T16:37:20-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prrn14a/0001140361-23-003464 2023-01-31T06:15:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defc14a/0001193125-23-019715 2023-01-31T08:02:39-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prrn14a/0001140361-23-003570 2023-01-31T16:13:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defc14a/0001140361-23-003597 2023-01-31T17:28:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-020496 2023-01-31T17:30:31-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-003852 2023-02-01T16:32:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-022871 2023-02-02T17:23:53-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-004220 2023-02-02T17:36:04-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-004481 2023-02-03T17:24:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-024795 2023-02-06T06:10:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-025756 2023-02-06T17:22:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-005062 2023-02-07T17:29:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-005127 2023-02-08T08:55:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13g/0000895421-23-000065 2023-02-08T14:33:00-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-005244 2023-02-08T17:07:46-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-030367 2023-02-09T17:22:42-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-005580 2023-02-09T17:22:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-005696 2023-02-10T06:17:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-006351 2023-02-13T16:36:04-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-036112 2023-02-13T17:22:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ct-order/9999999997-23-000544 2023-02-14T00:10:55-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-006545 2023-02-14T08:04:00-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-037536 2023-02-14T09:24:10-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-007054 2023-02-14T17:25:49-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-007234 2023-02-15T16:03:22-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-007294 2023-02-15T17:09:27-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-040330 2023-02-15T17:24:54-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-007501 2023-02-16T17:03:45-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-041198 2023-02-16T17:23:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-007589 2023-02-17T12:49:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-042123 2023-02-17T17:23:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-042135 2023-02-21T06:03:13-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-007712 2023-02-21T06:11:03-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-007713 2023-02-21T06:14:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-007833 2023-02-21T16:14:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-043600 2023-02-21T17:03:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-006077 2023-02-23T21:51:44-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-006080 2023-02-23T21:51:45-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-006079 2023-02-23T21:51:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-006076 2023-02-23T21:52:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-006081 2023-02-23T22:03:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-008863 2023-02-27T16:06:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-008862 2023-02-27T16:07:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-051033 2023-02-27T17:32:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-009092 2023-02-28T11:21:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/dfan14a/0001140361-23-009098 2023-02-28T11:30:41-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-23-005329 2023-03-01T07:09:00-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0000950170-23-005336 2023-03-01T07:34:58-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-057381 2023-03-02T08:47:48-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-061610 2023-03-06T17:29:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-007484 2023-03-08T08:33:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-007483 2023-03-08T08:34:31-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008169 2023-03-10T18:35:23-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008167 2023-03-10T18:35:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008166 2023-03-10T18:35:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008171 2023-03-10T18:35:24-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008172 2023-03-10T18:35:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008175 2023-03-10T18:38:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-008174 2023-03-10T18:38:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-086943 2023-03-31T09:05:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-23-012983 2023-04-17T08:15:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-23-000842 2023-04-24T01:15:26-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-23-000850 2023-04-24T01:17:19-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-23-016851 2023-04-24T01:18:00-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000899243-23-011832 2023-04-27T20:33:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-ka/0001193125-23-128994 2023-05-01T09:29:26-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-23-016878 2023-05-03T07:08:32-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-23-016877 2023-05-03T07:09:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0001193125-23-139564 2023-05-09T17:30:57-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-23-154694 2023-05-26T06:15:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/0001193125-23-154699 2023-05-26T06:24:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-163069 2023-06-08T08:59:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-016257 2023-06-22T17:13:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-173981 2023-06-23T17:30:51-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/defa14a/0001193125-23-174588 2023-06-26T09:20:42-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000899243-23-016904 2023-07-05T16:49:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-188876 2023-07-18T16:27:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-190185 2023-07-20T08:33:56-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033853 2023-07-21T17:05:36-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033855 2023-07-21T17:05:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033856 2023-07-21T17:08:35-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033899 2023-07-21T21:16:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033902 2023-07-21T21:16:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033900 2023-07-21T21:16:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033906 2023-07-21T21:17:03-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033912 2023-07-21T21:29:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033908 2023-07-21T21:29:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033909 2023-07-21T21:29:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-033911 2023-07-21T21:29:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-192541 2023-07-25T06:06:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000950170-23-035612 2023-07-28T18:50:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-23-036766 2023-08-02T07:03:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-23-036771 2023-08-02T07:10:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-3/0001193125-23-201187 2023-08-02T08:38:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0001193125-23-201194 2023-08-02T08:41:37-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-037291 2023-08-02T17:05:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-037295 2023-08-02T17:06:45-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-037305 2023-08-02T17:11:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-23-002398 2023-08-16T06:12:09-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-043073 2023-08-16T20:00:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-042674 2023-09-05T16:16:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-23-008430 2023-09-14T00:11:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-23-210694 2023-09-14T00:12:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-23-267198 2023-10-31T16:10:29-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-23-057120 2023-11-01T07:08:46-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-23-057121 2023-11-01T07:09:01-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-23-058858 2023-11-03T16:31:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000950170-23-065522 2023-11-21T16:39:56-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/corresp/0001193125-23-261753 2023-11-28T00:07:29-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-23-011730 2023-11-28T00:08:09-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/upload/0000000000-23-011112 2023-11-28T00:08:15-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13da/0001140361-23-056279 2023-12-05T07:40:46-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-068198 2023-12-05T16:32:08-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/sc-13ga/0000895421-23-000502 2023-12-08T16:27:38-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/144/0001950047-23-005910 2023-12-12T16:22:46-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-23-070510 2023-12-14T18:38:50-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-000313 2024-01-02T16:45:53-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-000322 2024-01-02T16:48:47-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-003082 2024-01-08T18:11:20-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-003081 2024-01-08T18:11:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-003511 2024-01-10T07:06:57-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-004302 2024-01-12T17:27:07-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-004305 2024-01-12T17:29:59-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-004308 2024-01-12T17:32:42-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-007006 2024-01-24T16:34:07-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-007688 2024-01-26T07:03:11-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-010536 2024-02-02T16:34:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-010534 2024-02-02T16:34:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-010535 2024-02-02T16:34:34-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-013289 2024-02-09T16:34:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-013290 2024-02-09T16:34:05-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-013294 2024-02-09T16:34:19-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0000950170-24-013569 2024-02-12T08:04:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-022635 2024-02-29T07:09:36-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0000950170-24-022636 2024-02-29T07:10:52-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0000950170-24-024353 2024-03-04T08:06:30-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/0001193125-24-058050 2024-03-04T17:33:16-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-040675 2024-04-03T08:03:39-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046053 2024-04-19T16:37:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046052 2024-04-19T16:37:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046049 2024-04-19T16:37:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046054 2024-04-19T16:37:13-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046058 2024-04-19T16:39:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046059 2024-04-19T16:39:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046062 2024-04-19T16:39:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-046064 2024-04-19T16:41:40-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-046290 2024-04-22T12:57:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-24-050886 2024-05-01T07:08:46-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/s-8/0000950170-24-050890 2024-05-01T07:12:45-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-050889 2024-05-01T07:12:45-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-065585 2024-05-29T06:06:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-068298 2024-06-04T07:33:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-076300 2024-06-21T16:34:50-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-079717 2024-07-01T16:56:50-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-087391 2024-07-29T17:32:18-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-088234 2024-07-31T07:08:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-24-088233 2024-07-31T07:08:12-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-089392 2024-08-01T16:57:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-089391 2024-08-01T16:58:21-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-24-090973 2024-08-05T17:34:07-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-113227 2024-10-07T17:06:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-118988 2024-10-30T16:12:42-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-24-118990 2024-10-30T16:14:17-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000950170-24-119593 2024-10-31T16:44:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-130263 2024-11-22T16:52:09-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-24-137894 2024-12-18T16:16:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-004271 2025-01-10T17:03:43-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-004275 2025-01-10T17:04:01-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-004273 2025-01-10T17:04:01-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-011822 2025-01-31T16:46:35-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-011823 2025-01-31T16:46:45-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-011824 2025-01-31T16:48:42-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-037618 2025-03-12T07:09:06-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0000950170-25-037620 2025-03-12T07:09:49-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6-pos/0001193805-25-000286 2025-03-12T07:47:55-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/0000899140-25-000466 2025-03-25T20:43:22-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-046873 2025-03-28T16:46:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0000950170-25-046874 2025-03-28T16:46:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-051353 2025-04-07T07:44:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/prer14a/0000950170-25-051358 2025-04-07T07:54:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-052305 2025-04-09T07:27:24-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-052307 2025-04-09T07:38:20-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0000950170-25-052674 2025-04-10T07:38:41-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/0001193125-25-078074 2025-04-10T17:04:25-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0000950170-25-053392 2025-04-11T18:03:14-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056930 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056928 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056932 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056929 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056931 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056925 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056926 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-056927 2025-04-22T21:07:23-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-060165 2025-04-29T16:25:28-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-064980 2025-05-07T07:08:41-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-25-064981 2025-05-07T07:10:15-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-072817 2025-05-15T17:02:42-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-089218 2025-06-24T07:07:53-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-091845 2025-06-30T21:34:11-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-ka/0000950170-25-093444 2025-07-03T06:10:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/f-6/0001104659-25-069672 2025-07-23T09:04:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0000950170-25-099878 2025-07-30T07:06:54-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0000950170-25-099879 2025-07-30T07:09:08-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/effect/9999999995-25-002436 2025-08-01T06:10:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0000950170-25-102119 2025-08-04T17:02:02-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-25-246973 2025-10-22T17:04:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-q/0001193125-25-254621 2025-10-29T07:10:47-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-25-254620 2025-10-29T07:12:05-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/3/0001193125-25-260850 2025-10-31T18:53:16-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-004718 2026-01-06T17:03:28-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-004722 2026-01-06T17:03:53-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-004719 2026-01-06T17:03:53-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-004724 2026-01-06T17:04:25-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-26-006992 2026-01-08T07:07:08-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-036166 2026-02-03T19:03:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-036169 2026-02-03T19:03:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-036165 2026-02-03T19:03:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-036164 2026-02-03T19:03:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-036167 2026-02-03T19:03:51-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-26-068511 2026-02-25T07:09:06-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/10-k/0001193125-26-085818 2026-03-02T17:35:26-05:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/8-k/0001193125-26-129334 2026-03-27T17:03:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/pre-14a/0001193125-26-132114 2026-03-30T17:59:33-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/4/0001193125-26-140264 2026-04-02T16:31:30-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/def-14a/0001193125-26-151417 2026-04-10T17:03:59-04:00 0.4 https://investor.amarincorp.com/sec-filings/sec-filing/ars/0001193125-26-151420 2026-04-10T17:04:17-04:00 0.4 https://investor.amarincorp.com/analyst/paul-choi 2019-10-17T15:54:48-04:00 0.5 https://investor.amarincorp.com/analyst/jessica-fye 2020-01-07T08:39:31-05:00 0.5 https://investor.amarincorp.com/analyst/roanna-ruiz 2023-11-02T13:53:49-04:00 0.5 https://investor.amarincorp.com/management/aaron-berg 2025-10-23T09:44:34-04:00 0.5 https://investor.amarincorp.com/management/jonathan-provoost 2025-06-03T14:18:46-04:00 0.5 https://investor.amarincorp.com/management/david-keenan-phd 2025-10-30T12:46:21-04:00 0.5 https://investor.amarincorp.com/management/steven-ketchum-phd 2025-06-03T14:21:23-04:00 0.5 https://investor.amarincorp.com/management/peter-fishman 2025-06-03T14:23:18-04:00 0.5 https://investor.amarincorp.com/board-directors/aaron-berg 2025-06-03T14:26:53-04:00 0.5 https://investor.amarincorp.com/board-directors/patrice-bonfiglio 2026-03-06T11:26:44-05:00 0.5 https://investor.amarincorp.com/board-directors/dr-paul-cohen 2026-03-06T11:52:14-05:00 0.5 https://investor.amarincorp.com/board-directors/keith-horn 2026-03-06T11:26:23-05:00 0.5 https://investor.amarincorp.com/board-directors/dr-odysseas-kostas-md 2026-03-06T11:26:30-05:00 0.5 https://investor.amarincorp.com/board-directors/louis-sterling-iii 2025-06-03T14:32:51-04:00 0.5 https://investor.amarincorp.com/board-directors/diane-sullivan 2025-06-03T14:33:17-04:00 0.5 https://investor.amarincorp.com/board-directors/oliver-oconnor 2026-03-06T11:26:36-05:00 0.5 https://investor.amarincorp.com/board-directors/michael-torok 2025-06-03T14:34:38-04:00 0.5 https://investor.amarincorp.com/management/eric-boothe 2025-11-04T20:04:38-05:00 0.5